Structure-function relationship of exchangeable apolipoproteins by Chetty, Palaniappan Sevugan




PALANIAPPAN SEVUGAN CHETTY 
Master of Science 




Submitted to the faculty of the 
Graduate College of the 
Oklahoma State University 
in partial fulfillment of 
requirements for the Degree of 
Doctorate of philosophy 
May, 2006   
 
ii






Chang An Yu (Chairperson) 
 
________________________________________ 
Jose L. Soulages (Advisor) 
 
________________________________________ 
Ulrich Melcher (Committee Member) 
 
________________________________________ 
Robert L. Matts (Committee Member) 
 
________________________________________ 
Robert Burnap (External Member) 
 
________________________________________ 




This work is a result of the exceptional mentoring from Dr. Jose L. 
Soulages and Estela L. Arrese; unfailing guidance of my committee members 
Drs. Ulrich Melcher, Chang-An Yu, Robert Matts and Robert Burnap and 
meticulous training in mass spectrometry from Dr. Steve Hartson. 
I would have not accomplished this goal without the blessings of my 
parents; the constant support from my wife and cumulative efforts of my friends 
and lab members. 
Finally, I would like to extend my regards to the Biochemistry Department 
and Core Facility for all the support extended during my stay at OSU.   
 
iv





Exchangeable apolipoproteins overview……………………………..1 
Insect apolipophorin-III………………………………………………....3 
Human apolipoprotein AI……………………………………………….8 
II. ESSENTIAL ROLE OF THE CONFORMATIONAL FLEXIBILITY OF 




 Site-directed mutagenesis 
 Protein expression and purification 
 Circular dichorism 
 Alkylation of double cysteine mutant 
 Protein determination 
 Kinetics of apoLp-III-DMPC interaction 
Results………………………………………………………………….20 
 Structural Properties of the Double Cys Mutant 
v
Kinetics of Formation of Discoidal Lipoproteins 
Discussion………………………………………………………………25 
III. IN VIVO LIPOPROTEIN BINDING ASSAY OF THE INSECT 
EXCHANGEABLE APOLIPOPROTEIN, APOLIPOPHORIN-III………………30 
Introduction……………………………………………………………..30 
Experimental Procedures……………………………………………..32 
 Recombinant Wild Type Locusta Migratoria apoLp-III 
 In vivo binding assays 
SDS PAGE and Western Blot Analysis 
Results and Discussion……………………………………………….34 
Rationale of assay..……………………………………………………36  
IV. ROLE OF HELICES AND LOOPS IN THE ABILITY OF APOLIPOPHORIN-III 




Site-Directed Mutagenesis and Protein Expression 
Alkylation of Cysteine Mutants 
Circular Dichroism 
Kinetics of the Spontaneous Formation of Discoidal           
Lipoproteins 
Preparation of ApoLp-III-DMPC Discoidal Complexes by 
Detergent Dialysis  
vi
Ultracentrifugation 
Discoidal DMPC Micelles 
In Vivo Lipid-Binding Activity of ApoLp-III Disulfide 
 Mutants 
Results………………………………………………………………….45 
 Characterization of the Disulfide Mutants 
Spontaneous Interaction of Disulfide Mutants with 
Multilamellar Vesicles (MLV) of DMPC 
Interaction of ApoLp-III Disulfide Mutants with Preformed 
Discoidal DMPC Micelles 
In Vivo Lipid-Binding Activity of ApoLp-III Disulfide Mutants 
Discussion………………………………………………………………54 
V. LIPID-BOUND CONFORMATION OF HUMAN APOLIPOPROTEIN AI......61  
Introduction……………………………………………………………..61 
Experimental Procedures……………………………………………..64 
 Purification of human Apolipoprotein AI from HDL 
Expression and purification of recombinant 15N labeled 
apoAI fusion protein 
Peptide Mass Fingerprinting of Human ApoAI and 15N
labeled Recombinant ApoAI Fusion Protein 
Preparation of 96Å rHDL particles 
Cross-linking of apoAI bound to rHDL particles 
In-gel Trypsin digestion 
vii
MALDI-TOF mass spectrometry of trypsin digests 
CNBr cleavage of 14N apoAI 
Peptide Mass Fingerprinting of CNBr fragments of DSP 
cross-linked apoAI dimers 
Results……………………………………………………………….....72 
 Protein Purification 
 Efficiency of In-gel Trypsin Digestion and 15N Labeling 
 Cross-linking of rHDL bound apoAI 
Peptide mass fingerprinting of control and cross-linked apoAI 
molecules 








LIST OF FIGURES 
 Page 
Figure-1 Schematic representation of a lipoprotein molecule. 2
Figure-2 Structure of Locust apoLp-III. 4
Figure-3 Models for lipid-binding associated conformational flexiblity of apoLp-III. 7
Figure-4 Structure of human apoAI solved by x-ray crystallography (PDB I.D. 2AO1).  9
Figure-5 Models for the orientation of apoAI molecules on reconstituted lipoprotein particles. 10
Figure-6 Tethering of the N-terminal and C-terminal helices of apoLp-III. 17
Figure-7 SDS-polyacrylamide gel electrophoresis of oxidized and reduced forms of disulfide mutant 21
Figure-8 Structural characterization of apoLp-III mutants 22
Figure-9  Effect of the disulfide bond tethering helices 1 and 5 on the kinetics of formation of discoidal lipoproteins. 24
Figure-10 In vivo binding of locust apoLp-III to Manduca sexta lipophorin 35
ix
Figure-11 
Position of the disulfide bonds tethering α-helices 3 
and 4 (H3-H4 mutant) and loops 2 and 4 (L2-L4 
mutant). 
46
Figure-12 Secondary structure of the ApoLp-III mutants 47
Figure-13 Spontaneous interaction of apoLp-III with multilamellar liposomes. 49
Figure-14 Interaction of ApoLp-III disulfide mutants with Cholate/DMPC mixed micelles. 50
Figure-15 Interaction of ApoLp-III disulfide mutants with Cholate/DMPC mixed micelles. 50
Figure-16 In vivo binding of Locusta migratoria ApoLp-III disulfide mutants to Manduca sexta lipophorin. 52
Figure-17 
Sketched representation of the extended 
conformations that could be adopted by different 
disulfide mutants in the lipid-bound state. 
56
Figure-18  Models of interaction of ApoLp-III with lipoprotein lipid surfaces. 58
Figure-19 
Coomassie blue stained 4-20% SDS-PAGE to 
monitor the purification of 14N apoAI  and 15N 
labeled recombinant apoAI-FP. 
72
Figure-20 Sequence coverage in peptide mass fingerprints of (a) 14N apoAI and (b) 15N apoAI-FP.  73
Figure-21 
PMF of 14N apoAI and 15N apoAI-FP to estimate the 
15N labeling efficiency by in-gel trypsin digestion and 
MALDI-TOF mass spectrometry. 
74
Figure-22 Coomassie Blue stained 4-20% non-denaturing gradient gel to monitor purification of rHDL particles. 75
Figure-23 Coomassie blue stained 4-20% non-reducing SDS-PAGE to separate DSP cross-linked products. 76
x
Figure-24 
12% SDS-PAGE to investigate the anomalous 
mobility of DSP cross-linked 14N apoAI molecules in 
the presence and absence of 6M urea. 
77
Figure-25 Structure of DSP, various types of DSP modifications and associated mass increase (Da). 78
Figure-26 
Coomassie blue stained 4-20% SDS-PAGE to 
monitor the purification of DSP cross-linked 14N 
apoAI by size-exclusion chromatography in sephacryl 
S-300 column. 
82
Figure-27 Estimating the size of 14N apoAI dimer by MALDI-TOF mass spectrometry. 83
Figure-28 16% Tris-Tricine SDS-PAGE to characterize the CNBr cleavage of 14N apoAI monomer and dimer. 83
Figure-29 Estimating the masses of CNBr fragments of 14N apoAI by MALDI-TOF mass spectrometry. 84
Figure-30 Purification of CNBr peptides of 14N apoAI monomers and cross-linked dimers. 86
Figure-31 
Comparison of the number of intrapeptide, 
intramolecular and intermolecular cross-links in apoAI 
trypsin peptides in three different reports.  
92
Figure-32 Gel-shift assay to monitor the formation of disulfide bonds in apoLp-III disulfide mutants. 104
Figure-33 Thermal unfolding of apoLp-III wild-type and oxidized disulfide mutants monitored by CD spectroscopy. 105
Figure-34 
The dimensions of a discoidal lipoprotein molecule 
used to calculate the lateral surface area of 
phospholipid acyl chains. 
107
xi
LIST OF TABLES 
 Page 
Table-1 
Heterogeneity in density, size and composition among 
various lipoprotein classes in Human and Insects 
lipoproteins 
2
Table-2 Distribution of lipophorin and apoLp-III among the KBr density fractions. 36
Table-3 Summary of Lipid-Binding Activity of the Disulfide Mutants of Apolipophorin-III 53
Table-4 Types of cross-linked samples used for in-gel digestion and PMF 68
Table-5 
 Estimated masses of DSP cross-linked 14N apoAI and 
15N apoAI-FP products based on relative mobility values 
(Figure-23) 
76
Table-6 Number of new m/z observed in peptide mass fingerprint of DSP modified apoAI molecules. 79
Table-7 Identification of DSP cross-linked peptides 80
Table-8 Cross-linked apoAI peptides identified in published reports . 90-91
Table-9 
Estimated transition temperatures for apoLp-III wild-type 
and disulfide mutants from the thermal unfolding plots in 
Figure-33.  
105
Table-10 Estimated lateral surface area of phospholipid disks. 107
xii
ABBREVIATIONS 
14N apoAI Wild-type human apoAI 
15N apoAI recombinant 15N labeled human apoAI fusion protein 
AKH Adipokinetic Hormone 
Apo Apolipoproteins 
ApoAI Apolipoprotein AI 
ApoAII Apolipoprotein AII 
ApoC Apolipoprotein C 
ApoE Apolipoprotein E 
ApoLp Apolipophorin 
ApoLp I Apolipophorin I 
ApoLp II Apolipophorin II 
ApoLp III Apolipophorin III 
BS3 (Bis[sulfosuccinimidyl] suberate)  
CD Circular dichorism spectroscopy 
CE Cholesterol esters 
CHD Coronary heart diseases 
CNBr Cyanogen bromide 
DG Diglycerides 
DMPC Dimyrsitoyl phosphatidyl choline 
DSP (Dithiobis[succinimidylpropionate])  
ESI Electrospray ionization 
 
xiii
HDL High density lipoprotein 
HDLp High density lipophorin 
ITC Isothermal titration calorimetry 
LCAT Lecithin cholesterol acyl transferase 
LC-ESI MS Liquid Chromatography-Electrospray ionization mass spectrometry 
LDL Low density lipoprotein 
LDLp Low density lipophorin 
Lp Lipophorin 
LTP Lipd transfer protein 
m/z mass/charge 
MALDI-TOF Matrix assisted laser desorption ionization time of flight 
MS Mass spectrometry 
NMR Nuclear magnetic resonance spectroscopy 
PMF Peptide mass fingerprinting 
POPC Palmitoyl oleyl phosphocholine 
TG Triglycerides 





Lipoproteins (lipophorins in insects) have a surface monolayer of 
phospholipids and cholesterol enclosing a central core of neutral lipids mostly 
cholesterol esters (CE) and triclycerides (TG) (Figure-1), in insects the core 
lipids are predominantly diglycerides (DG) (1, 2). The proteins associated with 
lipoproteins are of two types, the exchangeable apolipoproteins which readily 
exchange between various lipoprotein types or exist in the lipid-free or lipid-
bound state and integral or non-exchangeable apolipoproteins. There are three 
major classes of exchangeable apolipoproteins in humans, apolipoproteins class 
A, C and E designated as apoA, apoC and apoE with subclasses in each. In 
insects there is one exchangeable apolipoprotein apolipophorinIII (apoLp-III). The 
non-exchangeable apolipoproteins have a stronger interaction with the surface 
phospholipids and core lipids and are associated to specific lipoprotein types (1). 
Different combinations of apolipoproteins and lipids in human circulation lead to 
heterogeneity in the observed properties of lipoproteins like flotation densities (3)
(Table-1) or mobility in an electrophoretic field (4).  
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Organism Human Insects 







Density(g/ml) 1.063-1.21 1.019-1.063 0.93-1.006 0.93-1.006 1.065 1.03 
Protein (%) 50 20 10 1 50 40 
Major 









B,C-I, C-II, E ApoLp-III -- 
Phospholipid 
(%) 
30 24 19 4 14 7 
Cholesterol (%) 18 45 19 6 4 <1 
Triglycerides 
(%) 









Not Applicable 26 47 
Table-1: Heterogeneity in density, size and composition among various lipoprotein classes in 
Human and Insect lipoproteins (1, 2). 
 
Figure-1: Schematic representation of 
a lipoprotein molecule. 
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Based on the mobility in an electrophoretic field human lipoproteins are 
classified as having α mobility or β mobility. The densest lipoprotein high density 
lipoprotein or HDL moves farthest from origin, has α-mobility while the less dense 
very low density lipoprotein or VLDL has β mobility. LDL has an intermediate 
mobility (pre- β mobility) between HDL and VLDL. The least dense chylomicrons 
remain at origin. This difference in electrophoretic mobility is due to the presence 
of varying amounts of protein in the various lipoprotein classes. Based on 
heterogeneity in the lipid/protein composition in a specific class of lipoprotein 
type listed in Table-1 they may be further classified into subclasses based on 
density or electrophoretic mobility (1). 
Insect ApolipophorinIII (ApoLp-III):
ApoLp-III And Lipid Transport In Insect Hemolymph- ApoLp-III binding 
to LDLp and transport of DG to flight muscles is a well characterized process 
(reviewed in (2, 5) ). Adipokinetic hormone (AKH) is released from the corpus 
cardiacum of insects in response to a flight stimulus. AKH leads to lipolysis 
(synthesis of DG from TG) in the fat body. The newly synthesized DG is 
mobilized from the fat body to High Density Lipophorin (HDLp) by Lipid-Transfer 
Protein (LTP), eventually converting the HDLp to Low Density Lipophorin (LDLp). 
Free apoLp-III in the insect hemolymph binds to DG rich LDLp and aids in the 
transport of LDLp to the flight muscles where the DG molecules are used for 
energy production during flight. After the DG is delivered to the flight muscles the 
apoLp-III bound to LDLp goes to the lipid-free state in the hemolymph and LDLp 
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is converted back to HDLp. Thus the HDLp serves as a reversible shuttle in the 
transport of neutral lipids in insect hemolymph.  
Apolipophorin-III Structure- Apolipophorin-III (apoLp-III), a 17KDa (161 
residues) protein is synthesized in insect fat body and secreted into the 
hemolymph (2). In the lipid-free state apoLp-III exists as a five helix bundle. 
Locust migratoria (locust) apoLp-III structure was the first full length 
apolipoprotein structure to be solved by X-ray crystallography (6). The solution-
structures of apoLp-III from locust (7) and moth, Manduca sexta (8) have also 
been solved by NMR spectroscopy. ApoLp-III from both the insects is made up of 
5 amphipathic α-helices (H1-H5) arranged in an up-down (anti-parallel) topology 
connected by loops (L1-L4) (Figure-2). 
 
The NMR and crystal structures of locust apoLp-III are identical. This up-
down topology is also found in the N-terminal lipid binding 4-helical domain of 
human apolipoprotein E (apoE) (9). ApoLp-III from moth and locust share this 
Figure-2: Structure of locust apoLp-III, 
(Source: PDB, 1aep) 
5
high level of structural similarity despite having only 25% of primary sequence 
identity (10).  
ApoLp-III Lipid-Binding and Conformational flexibility-Surface 
Plasmon Resonance measurements of binding of apoLp-III to phospholipid 
bilayers as a function of DG concentration identified two steps in the process of 
lipid-binding of apoLp-III (11). A similar multi-step process has been proposed for 
the lipid-binding of human apoE and apoAI (12, 13). Surface-pressure 
measurements of apoLp-III at the air-water interface suggests apoLp-III to exist 
in a highly extended conformation on binding to lipids (14). Fluorescence 
resonance energy transfer between Trp113 in helix4 and introduced cysteine 
residues in helices 1, 2, 3 and 5 of apoLp-III suggest the five helices to adopt a 
highly extended conformation in the lipid-bound state (15). This observation is 
consistent with the surface pressure measurement studies.  Fluorescence 
quenching studies using nitroxide-labeled phospholipids and fatty acids suggest 
that all the five helices of apoLp-III interact massively with acyl chains in 
phospholipid discoidal lipoprotein complexes (16). 
Although, it is known that apoLp-III adopts a highly extended conformation 
on binding to lipids/lipoproteins and apoLp-III binding requires DG loading in the 
lipophorin molecules it is still not clear what triggers the conformational opening 
and the steps in reorganization of apoLp-III in going to a fully extended 
conformation. Conserved leucine (Leu 32, 34 and 95) residues in insect apoLp-III 
sequences were proposed to act as triggers in recognizing the hydrophobic 
defects on lipid surfaces eventually leading to the conformational reorganization 
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of the five helix bundle (6). Site directed mutagenesis of the conserved leucine 
residues 32, 34 suggests the leucines are not involved as hydrophobic triggers 
as proposed (17). There are three models to explain the initial steps in the lipid-
binding associated reorganization of the constituent α-helices of apoLp-III. The 
first model (Breiter, et. al, 1991) based on the crystal structure of apoLp-III 
identified L2 and L4 as the most flexible regions in apoLp-III based on the high B-
values (temperature factor) (6). This model proposed L2 and L4 to act as flexible 
hinges in the opening of the closed helix-bundle. In the process of binding to 
lipids the apoLp-III molecule opens asymmetrically by the putative hinges at 
loops 2 and 4 with helices 3 and 4 moving away from the helix bundle (Figure-
3a), to expose the hydrophobic core. The second model (18) was proposed 
based on the fluorescence anisotropy measurements of introduced Trp residues 
in each of the five helices of lipid-free apoLp-III. Helices 1 and 5 were identified to 
be the most flexible helices in lipid-free apoLp-III. According to this model the 
apoLp-III helix bundle opening was postulated to proceed through the separation 
of helices 1 and 5 (Figure-3b). The third model (7) based on the NMR structure  
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of locust apoLp-III proposed L4 to act as a molecular trigger in the recognition of 
hydrophobic defects on lipid-surfaces. Subsequent to the recognition of 
hydrophobic defect by L4 the helix-bundle was postulated to open asymmetrically 
by the flexible loops L1 and L3 leading to the movement of helices 2 and 3 away 
from the helix bundle (Figure-3c).   
No direct experimental evidence exists to support any of the three 
proposed models of apoLp-III helix-bundle reorganization. ApoLp-III goes from a 
compact globular structure to a fully extended conformation but how apoLp-III 
reaches the final lipid-bound state is still not clear. Two areas which need to be 
investigated to understand the lipid-binding associated conformational flexibility 
of apoLp-III are (a) identify regions of apoLp-III which initiate lipid binding and (b) 
identify the steps in the lipid-binding associated helix-bundle reorganization of 



















(C) Fan et,al, 2003
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apoLp-III. The full length atomic resolution structure of insect apoLp-III are 
known, this simplifies the use of site-directed mutagenesis to generate mutants 
and characterize the structure-function relationship of the apoLp-III molecule. 
Attempts have been made to apply the insight gained from the structure of insect 
apoLp-III to human exchangeable apolipoproteins (8). The fact that insect apoLp-
III shares the same amphipathic α-helical nature like human exchangeable 
apolipoproteins and the structural similarity with the N-terminal 4 helix-bundle of 
human apoE the insight gained by understanding the lipid-binding mechanism of 
apoLp-III can be applied to the human apolipoproteins. 
Human ApolipoproteinAI: 
Reverse Cholesterol Transport and Human ApoAI-Human apoAI is the 
major component of HDL in circulation. HDL mediates the transport of cholesterol 
from peripheral tissues to liver for catabolism in a process known as reverse 
cholesterol transport, (RCT) a vital process in the prevention of atherosclerosis 
and Coronary Heart Diseases (CHDs). Circulating HDL levels are negatively 
correlated with the incidence of atherosclerosis and CHDs. The role of HDL in 
RCT is largely mediated by the HDL bound apoAI molecules. Lipoprotein bound 
apoAI mediates the following functions: (i) leads to cholesterol and phospholipid 
efflux from cells; (ii)  activates HDL bound enzyme, lecithin-cholesterol acyl 
transferase (LCAT) which converts the free cholesterol from cells to cholesterol 
esters and transfers cholesterol esters to HDL core; (iii) maintains the structural 
integrity of HDL complexes containing phospholipids and cholesterol esters, and 
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(iv) binds to hepatic cell surface receptors leading to selective transport of 
cholesterol esters from HDL to hepatic cells (reviewed in (19-22)). 
Structure of Lipid-free Human ApolipoproteinAI (apoAI) - Human 
apoAI is a 243 residue polypeptide synthesized by the liver and intestine and 
secreted in the circulation. Lipid-free apoAI in solution exists as oligomers at 
concentrations > 0.1mg/mL. The full length crystal structure of lipid-free apoAI 
(Figure-4) has been reported recently (23). Human apoAI shares the helix 
bundle properties of insect apoLp-III and human apoE. 
 
Human ApoAI Lipid-Binding and Significance of Lipid-Bound 
Conformation-Deletion mutagenesis and Isothermal Titration Calorimetric 
studies (ITC) of human apoAI suggest the lipid-binding to be initiated by 
amphipathic α-helices in the C-terminal domain followed by the reorganization of 
amphipathic α-helices in the N-terminal and central domains (24). There are 
Figure-4: Structure of human apoAI 
solved by x-ray crystallography (PDB I.D. 
2AO1). Lipid-free apoAI is made up of 6 
amphipathic α-helices, residues 1-188 exist 
as a compact helical bundle. The C-terminal 
residues 189-243 exist as a pair of 
independent helices away from the compact 
N-terminal helical bundle.  
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three different models to explain the final lipid-bound conformation of apoAI in 
rHDL particles. The first model known as the ‘picket-fence’ model (Figure-5a and 
5b) was proposed based on Fourier transform infrared-attenuated total reflection 
spectroscopy (FTIR-ATR) studies which suggested the α-helices of human apoAI  
molecules to exist parallel to acyl chains on lipoprotein surface with adjacent 
apoAI molecules anti-parallel in orientation in terms of helix-sense (25). Studies 
utilizing FRET and molecular modeling support a ‘belt model’ which suggests two 
apoAI molecules to exist fully extended in an anti-parallel fashion with the 
constituent α-helices oriented perpendicular to the acyl chains of phospholipids 
(Figure-5c) (26, 27). The ‘hairpin model’ was proposed based on FRET studies 
where two apoAI molecules were suggested to exist folded as hairpins (Figure-
5d and 5e) on reconstituted HDL (rHDL) particles (28).  
 
Figure-5: Models for the orientation of 
apoAI molecules on reconstituted 
lipoprotein particles. N and C designate 
the N and C terminal of protein. (a) and (b) 
Picket-Fence Model, (c) Belt Model ,(d) 
Hairpin Model with two molecules in 
Head-tail conformation   and (e) Hairpin 
Model with two molecules in Head-Head 
conformation.  (Source- Biochemistry 
2001, 40, 5065-5074). 
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Recently two groups reported the structure of lipid-bound apoAI on rHDL 
investigated by chemical cross-linking using a 12Å homobifunctional cross-linker 
and mass spectrometry to differentiate between the three proposed models of 
apoAI organization on rHDL molecules described above (29-31). Both the 
models suggest an anti-parallel orientation of adjacent apoAI molecules in the 
edge of lipoprotein disks, but there are significant differences in the observed 
cross-linking data between the two groups.  
ApoAI can exist in various states of lipidation in the plasma or in rHDL 
molecules, which is reflected by the heterogeneity of HLD particle sizes reported 
in plasma (Table-1). Based on the ratio of apoAI to lipids, HDL molecules are 
classified as small pre-β-migrating HDL or discoidal HDL, and large spherical α-
migrating HDL3 or HDL2 (32). ApoAI is suggested to exist in different 
conformations based on the lipid content/size of HDL and studies suggest that 
these multiple conformation aid in regulating the various functions of apoAI 
mentioned earlier (33). It has been shown that the small rHDL particles or pre-β-
migrating HDL apoAI molecules in vitro can interact with cells and lead to 
efficient cholesterol efflux (34). Similarly the HDL associated enzyme LCAT is 
activated by residues 143-165 of lipid-bound apoAI only in pre-β-HDL molecules 
(35), while apoAI associated with cholesterol ester-rich spherical HDL2 particles 
or lipid-free apoAI do not activate LCAT (36). Immunological studies using 
monoclonal antibodies raised against specific apoAI epitopes suggest apoAI 
exists in a different conformation based on the phospholipid and cholesterol 
content (37). All these studies suggest apoAI exists in different conformations in 
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the lipid-bound state and it is essential to characterize the lipid-bound 
conformation of apoAI in varying sizes of lipoprotein particles to fully elucidate 
the mechanism of RCT. This will provide a clear insight as to the actual 
conformation of apoAI essential for various functions like cholesterol efflux or 




ESSENTIAL ROLE OF THE CONFORMATIONAL FLEXIBILITY OF HELICES 1 
AND 5 ON THE LIPID BINDING ACTIVITY OF APOLIPOPHORIN-III 
Introduction 
Apolipophorin-III (apoLp-III) is an exchangeable apolipoprotein found in 
the hemolymph of many insect species in a lipid-free state or bound to the major 
insect lipoprotein, lipophorin (2, 38). The structure of apoLp-III from two different 
insect species has been solved. The structures of Locusta migratoria and 
Manduca sexta apoLp-III were determined by x-ray crystallography (6) and NMR 
spectroscopy (8), respectively. The structure of apoLp-III is described as an 
elongated bundle of five amphipathic α-helices, where the nonpolar faces of the 
helices are oriented toward the protein core. A similar structure, but consisting of 
a four-helix bundle, is present in the N-terminal domain of human apoE (39). M. 
sexta and L.migratoria apoLp-III share a large number of physical-chemical 
properties with the apolipoproteins from humans and other vertebrates (8, 40, 
41). Among the common features of exchangeable apolipoproteins are their 
ability to reversibly bind to lipoprotein surfaces, their content and type of 
amphipathic α-helices(40), and their ability to form discoidal lipoprotein particles 
(42). 
The association of apolipoproteins with lipids is a complex process that 
involves several steps including protein conformational changes and the 
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disruption of the structure of the phospholipid monolayer or bilayer. Because of 
this complexity, the elucidation of the limiting steps and energy barriers involved 
in the formation of lipoproteins is also a complex task. Two processes were 
clearly distinguished in binding of apoLp-III to a planar lipid bilayer (11); the first 
process consisted in an adsorption of apoLp-III to the phospholipid bilayer, 
whereas the second process involved the insertion of the protein into the lipid 
bilayer and the formation of lipoprotein complexes (11). A recent study with 
disulfide mutants of apoE has shown that three binding steps involving different 
conformations of the protein can be distinguished along the pathway that leads to 
the formation of discoidal lipoproteins of apoE and DMPC (12). The initial binding 
step(s) of the apolipoprotein to the lipid surface may be envisaged as an 
adsorption process involving small structural changes in the protein. On the other 
hand, large conformational changes may be needed to achieve the final lipid-
bound state, which is thought to involve major interactions between the nonpolar 
faces of the amphipathic α-helices and the lipid surface (40-44). The role of the 
conformational flexibility is expected to be particularly important for 
apolipoproteins that have a defined tertiary structure, such as apoA-I, apoE, and 
apoLp-III. The nonpolar sides of the amphipathic α-helices of these 
apolipoproteins are mostly buried in the protein core, unavailable for interaction 
with a lipid surface. A recent spectroscopic study of single Trp mutants of L. 
migratoria apoLp-III in the lipid-free state showed that the helices 1 and 5 are 
characterized by a greater hydration and mobility than helices 2–4 (18). On the 
basis of the conformational flexibility of helices 1 and 5 and the relevance of this 
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property to the function of an exchangeable apolipoprotein, we suggested that 
the separation of the helices 1 and 5 could constitute an important step in the 
exposure of the hydrophobic core of the protein that is required to achieve the 
lipid-bound state (18). In order to investigate the validity of this model, we have 
designed a double Cys mutant, which allowed us to tether the helices 1 and 5 of 
apoLp-III and test the role of their conformational flexibility in the lipid binding 
properties of the apolipoprotein. The results of this study demonstrate an 
essential role of the conformational flexibility of the N- and C terminal helices in 




Site-directed Mutagenesis—Site-directed mutagenesis was carried out 
using the commercial kit, “QuickChange”, manufactured by Stratagene. A pET-
32a plasmid (Novagen, Madison, WI) containing the insert of L. migratoria 
apoLp-III was used for mutagenesis. The polymerase chain reaction containing 
the plasmid and the primers was performed according to the manufacturer 
instructions using the Pfu DNA polymerase. Competent cells, Epicurian 
(Stratagene), were transformed with the polymerase chain reaction. The plasmid 
DNA of the transformed bacteria was sequenced from the S-tag and T7-
terminator sites. AD494 expression host cells were transformed with the pET-
32aapoIII plasmids containing the correct sequences. Wild type L. migratoria 
apoLp-III contains no Cys residues and two Trp residues at positions 113 and 
128. The double Cys mutant was constructed using as template the single Trp 
mutant W128F. The reason for choosing the single Trp mutant instead of the wild 
type protein resides in the fact that the former is spectroscopically simpler and 
therefore will be useful for future fluorescence spectroscopic studies of the 
double Cys mutant. This strategy was possible because the structural and lipid 
binding properties of the single Trp mutant are indistinguishable from the 
properties of the wild type protein. The location of the Cys residues was chosen 
on the basis of the crystal structure of L. migratoria apoLp-III (aep1.pdb). The 
following substitutions were carried out: T18C (helix 1) and A147C (helix 5). The 
amino acid sequence surrounding the residues Thr18 and Ala147 are 
IAEAVQQLNHTIVNAAHEL and EAAEKTKEAAANLQNSIQS, respectively. A 
17
helical wheel representation obtained at the Web site of the ExPASy Molecular 
Biology Server indicates that Ala147 is located near the center of the hydrophilic 
face of the α-helix 5, whereas Thr18 is located near the interface of the polar and 
nonpolar faces of helix 1 (data not shown). On the other hand, from the crystal 
structure of apoLp-III, and using the program Insight-II, it was inferred that 
replacement of residues Thr18 and Ala147 by Cys would result in a protein 
containing a solvent-exposed disulfide bond (Figure-6). 
 
Protein Expression and Purification—Thioredoxin-apoLp-III fusion proteins 
were overexpressed and isolated from the bacteria as previously reported (15, 
18). The fusion proteins were purified by standard nickel affinity chromatography. 
Recombinant locust apoLp-III was cleaved from the rest of the fusion protein with 
Figure-6: Tethering of the N-terminal and C-
terminal helices of apoLp-III. Shown is the location 
of the disulfide bond in the mutantcontaining a Cys 
residue in helix 1 (Cys 18) and another Cys residue in 
helix 5 (Cys 147). Also shown is the single Trp residue 
at position 113. The location of the residues was 
represented using the crystallographic coordinates of 
ApoLp-III (aep.pdb) and the molecular modeling 
program Insight. 
18
enterokinase (Novagen, Madison, WI). ApoLp-III does not have any cleavage 
sites for enterokinase. ApoLp-III was purified from the cleavage reaction by nickel 
affinity chromatography and ion exchange chromatography in DE52. The purity 
of the proteins was monitored by SDS-polyacrylamide gel electrophoresis. 
Circular Dichroism—CD spectra were acquired in a Jasco-715 CD instrument 
using a 0.1-cm path length cell over the 190–250-nm range and a 1-cm path 
length cell in the near-UV (250–315 nm). The CD spectra were acquired at 25 °C 
every 1 nm with a 2-s averaging time per point and a 1-nm band pass. 
Alkylation of the Double Cys Mutant-After its purification, the recombinant 
double Cys mutant was recovered in a fully oxidized state, disulfide form. The 
Cys residues were alkylated with iodoacetamide. The reaction was performed in 
50 mM potassium phosphate buffer containing 100 mM iodoacetamide and  
dithiothreitol at pH 6.5. The excess of dithiothreitol and iodoacetamide was 
removed by dialysis. 
Protein Determination-The protein concentration in lipid-free apoLp-III 
samples was determined by UV absorption spectroscopy in the presence of 
guanidine HCl using an extinction coefficient of 5700 M-1 cm-1 for single Trp 
mutants and 11,400 M-1 cm-1 for the wild type protein, which contains two Trp 
residues. UV absorption spectra were recorded with a HP 8453 diode array 
spectrophotometer. 
Kinetics of ApoLp-III-DMPC Interaction-The kinetics of formation of 
discoidal lipoproteins of apoLp-III/DMPG or apoLp-III/DMPC was monitored by 
the decrease in absorbance at 325 nm that accompanies the transformation of 
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the multilamellar liposomes into discoidal lipoprotein particles as described by 
Pownall et al (45). The reactions were performed at 23.4 °C (DMPG) or at 23.9 
°C (DMPC), under continuous magnetic stirring, in a Hewlett Packard diode array 
spectrophotometer equipped with a temperature-controlled cell holder. The 
reaction was started by the addition of 50 µl of a liposome suspension (2.5 mg of 
phospholipid/ml). Data acquisition was started within 15 s after the addition of the 
liposomes. Because the reaction of apoLp-III is much faster with liposomes made 
of DMPG than DMPC (46), the kinetics using liposomes made with DMPG was 





Structural Properties of the Double Cys Mutant-Using the crystallographic 
structure of L. migratoria apoLp-III (6), the residues Thr18 and Ala147 were 
found suitable to design a disulfide bond tethering the centers of helices 1 and 5. 
The Cα atoms of these two residues have an optimal distance and orientation for 
the formation of a disulfide bond without altering the protein structure. The 
double-Cys mutant W128F/T18C/A147C was constructed, expressed, and 
purified. The ability of the double Cys mutant to form a disulfide bond was readily 
assessed by SDS-polyacrylamide gel electrophoresis gel shifts. As expected 
from other studies of disulfide-containing proteins (12, 47), in the oxidized form 
the double Cys mutant displays a greater electrophoretic mobility than in the 
reduced state (Figure-7). The reduced Cys mutant has the same electrophoretic 
mobility as apoLp-III molecules containing no Cys residues (wild type protein and 
W128F mutant). The intensity of the protein bands in Coomassie Blue-stained 
gels indicates that 100% of the protein is oxidized under nonreducing conditions. 
The double Cys mutant can be reduced by dithiothreitol in the presence of 
denaturants or SDS. However, in the native lipid-free state, this mutant 
spontaneously and rapidly reoxidizes to the disulfide form. Because the reducing 
agents interfere with the spectroscopic studies of the secondary and tertiary 
structure of the protein, it was chosen to alkylate the Cys residues with 
iodoacetamide, which does not modify the protein charge. The protein was 
readily alkylated by iodoacetamide, and its electrophoretic mobility was identical 
to that of the wild type protein (Figure-7). We will refer to the alkylated protein as  
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the reduced state of the double Cys mutant. A potential perturbing effect of either 
the mutations per se or the state of oxidation of the disulfide bond on the 
secondary structure of ApoLp-III was assessed by circular dichroism in the far- 
UV. Figure-8A shows the CD spectra of the double Cys mutant in the oxidized 
and reduced states as well as the spectra of the recombinant wild type apoLp-III 
and the single Trp mutant W128F, which was used to construct the double Cys 
mutant. Clearly, there are no significant differences among the far-UV CD 
spectra of the proteins. These results indicate that the formation of a disulfide 
bond or the alkylation of the Cys residues had no impact on the structure of 
apoLp-III. In every case, the CD spectra of the proteins were nearly identical and 
indicated that the proteins were highly α-helical. An estimate of the α-helical 
content using the method of Chen and Yang (48) indicates that the proteins 
contain between 56 and 62% of α-helix structure. Potential changes in the 
packing or tertiary structure of apoLp-III resulting from the mutations or the state 
Figure-7: SDS-polyacrylamide gel electrophoresis of oxidized and reduced forms of 
disulfide mutant. Lane 1, molecular weight markers; lane 2, disulfide mutant reduced state (10 
mM dithiothreitol+SDS); lane 3, molecular mass markers; lane 4, wild type ApoLp-III; lane 5,
W128F mutant; lane 6, disulfide mutant oxidized state; lane 7, alkylated disulfide mutant. 
Electrophoresis was performed in 16% polyacrylamide gels in Tris-Tricine buffer. The protein 
bands were visualized by Coomassie Blue staining. 
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of oxidation of the disulfide bond were investigated by near-UV CD spectroscopy 
(Figure-8b). The CD spectrum of the single Trp mutant containing no Cys 
residues (W128F) is dominated by the spectroscopic properties of the Trp 
residue. The intensity of the CD bands observed between 260 and 310 nm 
indicates strong packing constrains for this Trp residue, which is located in helix 
4. The addition of two Cys residues (T18C/A147C) does not change the CD 
spectrum of the Trp residue of apoLp-III in either the reduced or oxidized state of 
the disulfide bond. It is interesting to point out the apparent contribution of the 
disulfide bond in the near UV CD spectrum of the oxidized protein. It can be  
 
Figure-8: Structural characterization of apoLp-III mutants. A, far-UV CD spectra of oxidized and 
reduced forms of the double Cys mutant, W128F/T18C/ A147C. For comparison, the CD spectra of the 
wild type protein and the W128F mutant are also shown. All spectra shown were acquired in 50 mM 
potassium phosphate buffer, pH 6.5, at 25 °C. B, near-UV CD spectra of oxidized and reduced forms of 
the double Cys mutant and the control mutant W128F. The corresponding symbols are indicated. The 
spectrum of the wild type protein is not shown, because it has contributions from an additional Trp 
residue. 
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observed in the Figure-8 that between 250 and 270 nm, the intensity of the CD 
spectrum is larger when the Cys residues are forming a disulfide bond. This is 
the region where the CD absorption bands of the disulfide bond are 
expected(49). Overall, the CD studies indicated that the mutants were suitable to 
study the role of the conformational freedom of helices 1 and 5 on the function of 
apoLp-III. 
Kinetics of Formation of Discoidal Lipoproteins-The ability of apoLp-III to 
interact with liposomes and form discoidal lipoproteins particles was tested by 
studying the clearance of turbidity that occurs when exchangeable 
apolipoproteins interact with liposomes and induce the formation of discoidal 
lipoprotein particles (45). Multilamellar liposomes made of DMPC or DMPG were 
used in these assays. Figure-9 shows the decays of turbidity observed with 
several proteins; the reduced double Cys mutant T18C/QA147C spontaneously 
reacts with DMPC or DMPG liposomes with a reaction rate similar to that of 
observed with wild type recombinant apoLp-III or the W128F mutant. In 
agreement with a recent study on wild type L. migratoria apoLp-III (46), the 
reactions were faster with DMPG than DMPC. On the other hand, no differences 
were observed between the changes in optical density obtained with liposomes 
alone (blank) or in the presence of the disulfide form of the mutant. This result 
indicates that when the helices 1 and 5 are tethered by a disulfide bond, apoLp-
III is unable to form discoidal lipoprotein particles. A similar result is observed 
with either DMPC or DMPG liposomes. Moreover, the formation of discoidal 
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lipoproteins was not apparent even after 24 h of incubation of the liposomes with 




Figure-9: Effect of the disulfide bond 
tethering helices 1 and 5 on the kinetics 
of formation of discoidal lipoproteins. 
Reaction of apoLp-III with multilamellar 
liposomes of DMPC (A) or DMPG (B). The 
changes in optical density were monitored 
at 325 nm. Reactions with DMPG and 
DMPC were carried out at 23.4 and 23.9 
°C, respectively. The symbols for different 
apoLp-III samples are indicated. Additional 





Depending on the structure of the lipoprotein, two models are used to 
describe the interaction of the α-helices of exchangeable apolipoproteins with 
lipoprotein-lipid surfaces. For spherical lipoproteins, it has been proposed (39)
that the amphipathic α-helices have an orientation parallel to the phospholipid 
monolayer surface. In this case, the hydrophobic faces of the helices are 
embedded in the phospholipid monolayer, whereas the hydrophilic faces remain 
at the lipid surface and strengthen the lipid-protein interaction by means of ionic 
interactions with the charged groups of the phospholipid. On the other hand, in 
discoidal lipoprotein particles, the apolipoprotein is assumed to stabilize the 
lipoprotein particle by interacting with the acyl chains along the periphery of the 
lipid bilayer disc (27, 42, 44, 50, 51). In any of these two possible final lipid-bound 
states of the apolipoprotein, a massive interaction of the helices with the 
lipoprotein lipid surface is thought to take place. Therefore, the achievement of 
the final lipid-bound state must involve a massive conformational change 
probably involving the displacement of entire helices to allow the exposure of 
the protein hydrophobic core. This conformational change is expected to occur at 
least in some apolipoproteins, such as apoLp-III, apoE, and apoA-I, for which 
most nonpolar domains of the amphipathic α-helices are buried in the protein 
core. Thus, it is reasonable to assume that the conformational flexibility of the 
apolipoprotein may play a major role in the lipid binding process. Two alternative 
models have been introduced to explain the mechanism of opening of the helix 
bundle of apoLp-III required for the interaction with the lipid. The first model was 
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introduced by Breiter et al.(6), who on the basis of the crystal structure of apoLp-
III and previous studies suggesting that apoLp-III could adopt two conformations 
at the water-air interface (14) postulated that the five-helix bundle undergoes a 
lipid-triggered opening at putative hinge domains located between helices 2 and 
3 and between helices 4 and 5. This opening would expose a large extent of the 
hydrophobic interior of the protein allowing the lipid-protein interaction required 
for the final lipid-bound state. However, a subsequent study with M. Sexta apoLp-
III showed that cross-linking of the loops connecting helices 1 and 2 and helices 
3 and 4 did not prevent the apolipoprotein molecule from interacting with DMPC 
and forming recombinant lipoprotein particles (52). Therefore, we can infer that 
this mechanism is not taking place or that alternative mechanisms for the 
exposure of the hydrophobic domains can take place when the loops are 
tethered. We have recently introduced a second model proposing that one of the 
early conformational changes of apoLp-III during the lipid-binding process could 
involve spreading apart helices 1 and 5 (18). This model was based on 
experimental data indicating that helices 2–4 of apoLp-III constituted a well 
packed domain, whereas helices 1 and 5 were more mobile and hydrated as well 
as on the assumption that the conformational flexibility constitutes a key property 
of exchangeable apolipoproteins (18). To test the validity of this model, we 
investigated the effect of decreasing the conformational flexibility of helices 1 and 
5 on the lipid binding activity of the apolipoprotein. For this purpose, we 
constructed a double Cys mutant that in the disulfide state tethered the centers of 
helices 1 and 5 of apoLp-III. The structure of this mutant as studied by circular 
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dichroism indicated that the mutations and the formation of the disulfide bond did 
not introduce a major perturbation in the secondary structure of the protein. 
Moreover, the internal packing of the protein, as determined by the packing 
constraints of the single Trp residue, was not altered, indicating that the disulfide 
mutant in either the alkylated state or the oxidized state was suitable to the study 
of the functional role of the conformational flexibility of helices 1 and 5. The 
results obtained in the kinetics of formation of discoidal lipoproteins clearly 
showed that in the oxidized state the disulfide mutant is unable to promote the 
formation of discoidal lipoproteins when incubated with either DMPC or DMPG 
liposomes. These results indicate that the separation of helices 1 and 5 
constitutes a key step in the formation of discoidal lipoproteins.  
Alternative mechanisms for the exposure of the hydrophobic core of the 
disulfide-tethered protein are in principle available. For instance, the helical 
bundle of the disulfide-tethered apoLp-III could still relax and expose its 
hydrophobic core to the lipid surface by breaking the interactions between any of 
the other four pairs of neighboring α-helices or by a mechanism similar to that 
proposed by Breiter et al. (6), in which the interactions between two pairs of 
helices are simultaneously broken. In this regard, a recent study of disulfide 
mutants of apoE clearly showed that alternative mechanisms of opening of the 
helix bundle are available to apoE (12). The study with human apoE showed that 
tethering any of the four contiguous pairs of α-helices with a disulfide bond was 
not enough to prevent the formation of discoidal lipoproteins. Three disulfide 
bonds, which effectively prevented opening of the helix bundle, were required to 
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abolish the ability of apoE to spontaneously interact with DMPC liposomes and 
form discoidal lipoproteins (12). Given the similarities in structure and functional 
properties shared by the N-terminal domain of human apoE and the full-length 
apoLp-III (38, 43) and the demonstration that alternative lipid-binding 
mechanisms are available for human apoE (12), it was particularly surprising to 
find that only one disulfide bond was able to abolish the ability of apoLp-III to 
form discoidal lipoproteins. The inability of the disulfide mutant of apoLp-III to 
form discoidal lipoproteins clearly indicates that the conformational freedom of 
helices 1 and 5 is essential to the lipid binding process and cannot be substituted 
by alternative conformational changes. 
The association of apolipoproteins with a lipid surface is  a complex 
process that involves several steps including protein conformational changes as 
well as changes in the structure of the lipid surface. Because of this complexity, 
the elucidation of the key steps and energy barriers involved in the 
apolipoprotein-lipid interaction is a difficult task. Evidence for the existence of at 
least two binding steps has been reported for apoE  (11)and for apoLp-III (12). 
The initial binding step of the apolipoprotein to the lipid surface may be 
envisaged as an adsorption process and could involve a small protein domain. 
This small domain could be a permanent surface domain or a result of short 
range conformational fluctuations. Contrarily, to reach the final lipid-bound state, 
which involves the interaction of large helical regions with the lipid surface, the 
apolipoprotein must undergo a major conformational change. This conformational 
change is likely to take place in several steps that gradually increase the extent 
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of the lipid-protein interaction to achieve the final lipid-bound state. Among these 
steps, long range concerted movements of entire helices might be needed. The 
fact that tethering the helices 1 and 5 of apoLp-III renders an inactive 
apolipoprotein suggests that the movement of helices 1 and/or 5 away from the 
helix bundle constitutes one of the key and early steps along the complex 
pathway for the formation of the final apolipoprotein lipid-bound state. Further 
investigations on the role of helices 1 and 5 in the lipid-protein interaction will be 
necessary to obtain additional insights into the mechanism of lipid binding. In this 
regard, the study of the arrangement of the helices in the lipid-bound state may 
prove to be useful for the understanding of the relevance of helices 1 and 5 in the 




IN VIVO LIPOPROTEIN BINDING ASSAY OF THE INSECT EXCHANGEABLE 
APOLIPOPROTEIN, APOLIPOPHORIN-III 
Introduction 
Lipophorin is the only lipoprotein found in insects. It is composed of two 
structural apolipoproteins similar to human apoB (apoLp-I ~240kDa and apoLp-II 
~ 80kDa) and one exchangeable apolipoprotein, apolipophorin-III (apoLp-III, 
17kDa). ApoLp-III is an exchangeable apolipoprotein, which is present in the 
hemolymph of several insects in a lipid-free form, and bound to lipophorin 
particles of different density (2). 
Exchangeable apolipoproteins are essential structural and functional 
protein of circulating lipoproteins (53). The most common approach to study the 
relationship between the structure and the function of exchangeable 
apolipoproteins resides in the production of mutants of the apolipoprotein 
molecules and the study of the impact of the mutations in the lipid-binding 
properties of the molecule. Several lipid-binding assays are used for this 
purpose. The most commonly used techniques include: 1) the liposomal 
clearance assay (45), which determines the ability of the protein to interact 
spontaneously with liposomes and lead to the formation of discoidal lipoproteins; 
2) leakage of liposome content assay (54), which determines the ability of the 
protein to perturb the packing of a phospholipid bilayer; 3) detergent facilitated 
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formation of discoidal lipoproteins (55), which studies the ability of the 
protein to form discoidal lipoproteins upon incubation with mixed micelles of 
phospholipid and cholate; 4) inhibition of phospholipase C dependent lipoprotein 
aggregation (56). 
Binding of apoLp-III and exchangeable apolipoproteins with lipids is a 
complex multistep process (11, 12). The use of different assays to study the lipid 
binding activity apolipoproteins is necessary to elucidate the mechanism of the 
lipid-protein interaction. However, from a physiological point of view, as well as a 
tool to investigate the lipid-protein interaction, it is also important to count with a 
method to study the lipid binding properties of mutant apolipoproteins to native 
lipoprotein particles. In this study we report an original in vivo binding assay for 




Recombinant Wild Type Locusta Migratoria apoLp-III-Wild type locust 
apoLp-III was expressed in a pET32a expression vector containing an insert of 
thioredoxin-wild type apoLp-III fusion protein. The procedure followed for the 
expression and purification of apoLp-III has been previously reported (18, 57). 
In vivo binding assays-2 to 3 day old adult (moth) insects from our 
laboratory colony were selected and injected with 20µg of locust wild type apoLp-
III dissolved in 30µL of phosphate buffered saline. Hemolymph was collected 30 
min. after the injection of locust apoLp-III and subjected to fractionation by 
ultracentrifugation in a KBr gradient, at 350,000 x g, at 4°C for 1 hour in a VTi 
65.2 rotor (58). The gradient was fractionated into four fractions, fraction-1 
(LDLp, density <1.05), fraction-2 (HDLp, density 1.06-1.11 g/cm3), fraction-3 
(HDLp, density 1.12-1.16 g/cm3) and fraction-4 (free protein, density 1.17-1.25 
g/cm3). The fractions were dialyzed against 25mM phosphate buffer, pH6.5 
containing 0.002% sodium azide for 2 hours at room temperature and used for 
SDS PAGE and western blot analysis. 
SDS PAGE and Western Blot Analysis-To allow a direct quantitative 
estimation of the amounts of apoLp-III in the lipid-free and lipidbound fractions, 
proportional volumes of the KBr density fractions were loaded into a 4-20% Tris-
glycine polyacrylamide gel. Standard Coomassie staining was used to visualize 
M. sexta apoLp-I, apoLp-II and apoLp-III bands. The stained gel was scanned 
horizontally and analyzed by densitometry to determine the relative abundance of 
apoLp-III and lipophorin in different density fractions. An identical gel was blotted 
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onto nitrocellulose membranes by semi-dry transfer in a Trans-Blot SD 
instrument (Bio-Rad, CA) and used to determine the amounts of locust apoLp-III 
in the lipoprotein fractions and in the lipid-free fractions (unbound). The blotted 
membrane was probed with a primary rabbit anti-locust apoLp-III antibody and a 
secondary goat-anti-rabbit IgG with a horseradish peroxidase tag. The bands 




Results and Discussion 
 Manduca sexta hemolymph contains 1-1.5mg of apoLp-III at a 
concentration of 20-30mg/ml. Ultracentrifugation of the hemolymph in a KBr 
density gradient readily separates lipid-free apoLp-III, which accumulates at the 
bottom of the gradient, from lipophorin-bound apoLp-III. Lipophorin-bound apoLp-
III is distributed between high-density lipophorin, HDLp, and low-density 
lipophorin, LDLp, subspecies. These lipoprotein fractions are found in the top-half 
of the gradient (Figure-10a). HDLp and LDLp are interconverted in circulation by 
gaining, or losing, lipid molecules and apoLp-III (5, 59-62). This study was carried 
out with resting insects. Under this condition, nearly 40 % of Manduca sexta 
apoLp-III is found in the lipid-free fraction (Figure 10a, and Table-2) and the 
remaining is distributed between LDLp and HDLp. The presence of LDLp in 
resting Manduca sexta moths is a well-known fact (62, 63). 
Because apoLp-III molecules from these two insect species share 
identical functions and structures (64), the possibility of studying the in vivo lipid 
binding activity of Locusta migratoria apoLp-III using Manduca Sexta (moth) 
insects was investigated. Given the fact that the sequence identity of locust and 
moth apoLp-III molecules is very low (2), antibodies raised against one of these 
molecules do not cross-react with the other apoLp-III. Therefore, we have made 
use of antibodies to detect and quantify the distribution of locust apoLp-III 
between the lipid-free and lipoprotein bound fraction. As shown in Figure-10b, 
wild-type locust apoLp-III binds to Manduca sexta lipoproteins, LDLp and HDLp, 
and distributes between the lipid-free and lipid-bound fractions in a fashion  
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similar to that of Manduca sexta apoLp-III (Figure-10a). The amount of locust 
apoLp-III bound to lipophorin was estimated semi-quantitatively by scanning 
densitometry. In this assay ~ 26% of the locust apoLp-III was found bound to 
LDLp, ~34% bound to HDLp, and the remaining 40% was found in the lipid free 
fraction. The distribution of Locusta migratoria apoLp-III between the density 
fractions of the hemolymph is nearly identical to the distribution of Manduca 
sexta apoLp-III (Table-2) indicating that wild type locust apoLp-III and Manduca 
sexta apoLp-III have similar lipid binding affinities for lipophorin. 
 
Figure -10: In vivo binding of locust apoLp-III to Manduca sexta lipophorin. a) Coomassie Blue 
stained, 4-20% SDS-PAGE of the hemolymph fractions obtained by ultra-centrifugation in a KBr 
density gradient; b) Western blot with anti-locust apoLp-III IgG. 
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Table-2: Distribution of lipophorin and apoLp-III among the KBr density fractions. The relative 
amounts of lipophorin and apoLp-III in the gradient fractions of Manduca sexta hemolymph were estimated 
by scanning- densitometry of the Coomassie blue stained gel as indicated in Experimental Procedures. 
This study indicates that the lipid binding activity of recombinant locust 
apoLp-III can be assayed in vivo. Coupled to site directed mutagenesis, this 
simple in vivo binding technique is expected to be very useful to study the 
relationship between the structure and function of exchangeable apolipoproteins. 
Rationale of the Assay 
Referring to the concentration of lipid-free Manduca sexta and Locusta 
migratoria apoLp-III as CA and CB, respectively, the following two equilibriums 
must be satisfied in the hemolymph: 
KA= CA (n – ν) / νA (1) KB= CB (n –ν) / nB (equation-1) 
 
Where n is the total number of binding sites in lipophorin and ν is the 
number of occupied binding sites. 
ν = νA + νB, and the terms (n –ν) in (1) and (1’) are identical because both 
equilibriums occur simultaneously. Thus the ratio of 1/1’ is: 
KA/ KB = CA νB /CB νA (equation-2) 
C and ν can be expressed as function of the total apolipoprotein 
concentration and the mole fractions of bound and free apolipoprotein as:  
CB = CB(total) (1 – XB(bound)) , and νB = CB(total) XB(bound)  
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A similar relationship exists for A, and replacing these relationships in 
(equation-2): 
KA/ KB = (1 – XA(bound)) XB (bound) / (1 – XB (bound)) XA(bound) (equation-3) 
This relationship (equation-3) shows that the ratio of the dissociation 
constants for the host and the test apolipoproteins is only related to the fractions 
of bound and free proteins. Therefore, determining these fractions we can 
determine the lipid binding affinity of a test apoLp-III relative to the lipid binding 




ROLE OF HELICES AND LOOPS IN THE ABILITY OF APOLIPOPHORIN-III 
TO INTERACT WITH NATIVE LIPOPROTEINS AND FORM DISCOIDAL 
LIPOPROTEIN COMPLEXES 
Introduction 
Apolipophorin-III (apoLp-III) from the hemolymph of the locust (Locusta 
migratoria) is an exchangeable apolipoprotein with a molecular mass of ~17 kDa 
(14). ApoLp-III participates in transporting lipids among the insect tissues (2, 65). 
The X-ray crystal structure of L. migratoria apoLp-III in the lipid-free state 
indicates that the protein has an overall shape of a prolate ellipsoid, composed of 
a bundle of five amphipathic α-helices (6). Similar structures were recently 
inferred for Manduca sexta and L. migratoria apoLp-III by NMR spectroscopy (7, 
66). Both insect apoLp-III molecules share structural and physiochemical 
properties with the N-terminal four-helix bundle (22 kDa) of the human 
apolipoprotein E (apoE) (39). 
Binding of exchangeable apolipoproteins to the lipoprotein lipid surface is 
a complex process, which is likely to involve several steps and changes in the 
protein structure as well as changes in the structural organization of the lipid 
molecules. Binding of human ApoA-I to lipids has been suggested to occur in a 
multistep process (67, 68) involving an initial adsorption followed by penetration 
of the amphipathic R-helices into the phospholipid bilayer. On the basis of the  
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lipid-binding activity of disulfide mutants, a similar multistep process has been 
suggested by Lu et al. (12) for human apoE. These studies indicate an initial 
interaction of apoE with the lipid surface without major helical rearrangements 
followed by a major rearrangement of constituent R-helices of apoE. Two steps 
in binding of apoLp-III to a planar bilayer were also distinguished by surface 
plasmon resonance (11). The interaction of apolipoproteins with lipid surfaces is 
dependent on the properties of both the protein and the lipid surface. The 
changes in lipid composition of lipoproteins that take place in circulation 
constitute the driving forces for binding of the apolipoproteins to the lipoprotein, 
as well as to their dissociation from the lipoprotein lipid surface. On the other 
hand, the properties of the protein define the rate of the binding process and the 
affinity of the bound state (69, 70). One of the common features of exchangeable 
apolipoproteins resides in their ability to undergo conformational changes (71). 
The conformational flexibility of apolipoproteins (70), and membrane-binding 
proteins (72), may be required for the initial binding steps, such as the adsorption 
of the protein to the lipid surface, as well as for subsequent structural changes 
that would lead to a final lipid-bound state. 
 To investigate the role of the conformational flexibility of different regions 
of the apoLp-III molecule and its mechanism of interaction with lipid surfaces, 
disulfide mutants were designed on the basis of the crystal structure of the 
protein. Two disulfide mutants restricting the conformational flexibility of the 
neighboring α-helices 1 and 5 (H1-H5) and 3 and 4 (H3-H4) and one disulfide 
mutant tethering the second and fourth loops (L2-L4) were successfully 
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constructed and expressed. The ability of these mutants to form discoidal 
lipoproteins upon interaction with both phospholipid bilayers and preformed 
discoidal micelles was investigated. Moreover, the lipid-binding activity of the 
proteins was studied in vivo providing information on the mechanism of 
interaction of apoLp-III with native spherical insect lipoproteins. The comparison 
of the lipid-binding properties of these mutants provided information about the 
role of different regions of the apoLp-III molecule in the insertion of the protein 




Site-Directed Mutagenesis and Protein Expression-Wildtype apoLp-III was 
cloned in a pET32a expression vector (Novagen, Inc., Madison, WI) and used as 
template for sitedirected mutagenesis. Mutagenesis was carried out using the 
QuickChange kit from Qiagen Sciences, MD. The procedures followed for the 
expression and purification of wild-type and cysteine mutants of apoLp-III are the 
same as reported earlier (57, 73). The proteins were expressed in bacteria as 
thioredoxin-apoLp-III fusion proteins, cleaved with enterokinase, and purified by 
affinity chromatography. To facilitate the spectroscopic characterization of the 
proteins, the disulfide mutants were constructed after obtaining the single Trp 
mutant W128F, which has structural and lipid-binding properties similar to the 
wild-type protein (15). The location of the residues potentially suitable for the 
formation of a disulfide bond was selected by visual inspection of the crystal 
structure (1aep PDB) and replaced by Cys using the molecular modeling 
program Insight-II. The distances between the S-atoms were measured for 
different combinations of rotamers of the Cys side chains. Those residues that 
provided the shortest distance of separation between the sulfur atoms were 
selected for mutagenesis. The mutant H3-H4, which tethers the centers of α-
helices 3 and 4, has the following substitutions: W128F, N81C (helix-3), and 
Q112C (helix-4). The mutant L2-L4, which tethers the loops connecting helices 2-
3 and 3-4, has the following substitutions: W128F/S70C/A127C. The construction 
and expression of T18C/A147C has been reported earlier (73). 
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Alkylation of Cysteine Mutants-The purified double cysteine mutants were 
fully oxidized (disulfide state). To study the reduced form of the mutants, it was 
necessary to alkylate the Cys residues. Alkylation was carried out with 
iodoacetamide as described previously (73). 
 Circular Dichroism-Far and near UV CD spectra were obtained in a Jasco-
715 CD instrument, as described previously (73). The concentration of the free 
apoLp-III mutant and wild-type were determined by UV absorption spectroscopy 
in the presence of 3 M Gdm-HCl. 
Kinetics of the Spontaneous Formation of Discoidal Lipoproteins-The 
kinetics of formation of discoidal lipoproteins was studied using multilamellar 
vesicles of DMPC, as described by Pownall et al. (45). The reaction was 
performed at 23.9 °C, in 50 mM potassium phosphate buffer pH 6.5, with 
continuous magnetic stirring in a Hewlett-Packard 8453 diode array 
spectrophotometer equipped with a temperature-controlled cell holder at a 
protein to lipid molar ratio of 1:20. The reaction was started by the addition of 25 
µL of 2.5 mg/mL DMPC (MLV), and data acquisition was started within 15 s after 
the addition of liposomes. Data were acquired continuously over a 30 min time 
period. 
 To determine the sizes of lipoprotein disks formed by spontaneous 
interaction, a concentrated sample of apoLp-III and MLV of DMPC (47.5 µM
protein in a final volume of 40 µL) was prepared using a 1:20 protein to lipid 
molar ratio. ApoLp-III was incubated for 24 h with MLV of DMPC at 23.9 °C, and 
43
then, the reaction mixture was subjected to nondenaturing gradient PAGE in 4-
20% gels for 12 h at 120 V. 
Preparation of ApoLp-III-DMPC Discoidal Complexes by Detergent 
Dialysis- Discoidal complexes of apoLp-IIImutants and DMPC were prepared by 
a cholate dialysis method (55) using a protein/DMPC/cholate molar ratio of 
1:60:60. Cholate was removed from the mixture by extensive dialysis against 25 
mM potassium phosphate buffer, 125 mM NaCl, pH 7.3. After dialysis, the 
apoLp-III/DMPC complexes were characterized by nondenaturing gradient gel 
electrophoresis and KBr density gradient ultracentrifugation. The sizes of the 
lipoprotein particles were calculated from the Rf values and calibration curve of 
the high range molecular weight markers (Pharmacia). 
Ultracentrifugation-The lipoprotein complexes formed by cholate dialysis 
were characterized by ultracentrifugation in a KBr density gradient (58). The 
samples (0.1 mL, 100 µg of protein) were mixed with 2.0 mL of KBr solution 
(0.5g/mL), prepared in buffer 0.15 M NaCl, 0.001% EDTA, pH 7.5, and loaded in 
OptiSeal polyallomer tubes (Beckman Instruments, Inc. Palo Alto, CA). The 
samples were over layered with 2.9 mL of saline and centrifuged at 328 000g in a 
VTi-65.2 vertical rotor. After centrifugation, each tube was fractionated, and the 
density of the fractions was estimated by refractometry. The protein 
concentration was estimated from the second derivative spectra of the fractions. 
In Vivo Binding of Recombinant L. migratoria apoLp-III to M. sexta 
Lipophorin. Binding of the disulfide mutants or wild-type locust apoLp-III to native 
spherical lipoproteins was studied in vivo as recently described (74). Adult male 
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M. sexta insects were injected with 20 µg of locust apoLp-III mutant. Hemolymph 
was collected 120 min after the injection of the protein and subjected to 
fractionation by ultracentrifugation in a KBr gradient. The fractions were dialyzed 
against 25 mM phosphate buffer, pH 6.5, for 2 h at room temperature and used 
for SDS-PAGE and Western blot analysis. The relative amounts of locust apoLp-
III associated with each fraction were determined by Western blotting using a 
rabbit anti-locust apoLp-III antibody. The blot was developed by 




The conformational flexibility of different helical and loop regions of apoLp-
III was restricted by means of disulfide bonds, and the effect of the disulfide 
bonds on the ability of apoLp-III to form lipoprotein complexes was investigated 
in three different lipid-binding systems. In the first group of experiments, the 
ability of apoLp-III mutants to form lipoprotein complexes upon spontaneous 
interaction with liposomes of phosphatidylcholine was studied. In a second group 
of experiments, the ability of apoLp-III mutants to form discoidal lipoproteins upon 
interaction with discoidal mixed micelles of phosphatidylcholine and Na+-cholate 
was investigated. Finally, the ability of apoLp-III mutants to interact with native 
spherical insect lipoproteins was studied in a novel in vivo lipid-binding assay. 
Characterization of the Disulfide Mutants-The location of the Cys residues 
was selected on the basis of the coordinates reported with the crystal structure of 
apoLp-III (6), taking into account the predicted distances and angles of 
orientation between the sulfur atoms of the Cys residues. The disulfide bonds 
were designed to reside on the protein surface to minimize potential 
perturbations in the internal packing of the protein. Three disulfide mutants of 
apoLp-III were designed and expressed: the H3-H4 (N81C/Q112C) and H1-H5 
(T18C/A147C) mutants have a disulfide bond tethering the centers of helices 3 
and 4 and 1 and 5, respectively. The L2-L4 mutant (S70C/A127C) has a disulfide 
bond linking the second and fourth loops of the five-helix bundle of apoLp-III. The 
position of the Cys residues in the H3-H4 mutant and L2-L4 mutant 
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(S70C/A127C) is illustrated in Figure-11. The location of the disulfide bond on 
the H1-H5 mutant has been reported already (73). 
 
ApoLp-III mutants were expressed and purified to homogeneity. The 
difference between the electrophoretic mobility of oxidized and reduced disulfide 
mutants was used to investigate the formation of the disulfide bonds (12, 47, 73). 
The formation of disulfide bonds was complete for all mutants included in this 
study (See Appendix). 
The far UV CD spectra of oxidized and reduced (alkylated) forms of the 
H3-H4 and L2-L4 mutants (Figure-12) showed that the proteins are 
predominantly α-helical. The wild-type protein and the disulfide mutants H3-H4  
FIGURE-11: Position of the disulfide 
bonds tethering α-helices 3 and 4 (H3-
H4 mutant) and loops 2 and 4 (L2-L4 
mutant). The location of the single Trp 
residue, W113, of these mutants is also 
shown. 
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and L2-L4 have α-helical contents of 61, 61, and 55%, respectively. Reduction of 
the disulfide bonds by alkylation decreased the α-helical content of both the H3-
H4 and the L2-L4 mutants to 41%. As reported before (73), the estimated α-
helical content of the oxidized H1-H5 is nearly identical to that of the wild-type 
protein. The structure of the mutants was also studied by fluorescence 
spectroscopy. The disulfide mutants used in this study contain a common single 
Trp residue in helix4 (W113, Figure 11). For all mutants, the fluorescence 
maximum was located at 314-315 nm, which is consistent with the nonpolar 
environment expected for the single Trp residue (18, 75). 
 Spontaneous Interaction of Disulfide Mutants with Multilamellar Vesicles 
(MLV) of DMPC-The kinetics of the formation of discoidal lipoproteins upon the 
spontaneous interaction of apoLp-III with MLV of DMPC was monitored 
spectrophotometrically. The transformation of the large MLV into small discoidal 
FIGURE-12: Secondary structure 
of the ApoLp-III mutants. The 
figure shows the far-UV CD spectra 
of the proteins used in this study. 
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lipoproteins is accompanied by a nearly complete clearance of the turbidity of the 
reaction mixture. Figure-13A shows the turbidity decays obtained for the 
disulfide mutants in both reduced and disulfide states as well as the decay 
obtained with the wild-type protein. In the reduced state, the mutants H3-H4 and 
L2-L4 clear the liposomal turbidity completely and at a rate comparable to that of 
the wild-type protein. However, both H3-H4 and L2-L4 mutants appear to be 
inactive in the oxidized state. It has been previously shown that the mutant H1-
H5 is unable to interact with MLV of DMPC in the disulfide state but associates 
normally upon reduction (73). 
Because of the short time span of the turbidimetric assay, a mutant 
characterized by a very slow rate of formation of discoidal lipoproteins could be 
seen as an inactive protein. To investigate this possibility, the ability of the 
mutants to form discoidal complexes was also studied using longer incubation 
times (24 h) and a higher protein and lipid concentration (45 µM protein) than that 
used in the turbidity assay (~4 µM). After incubation, an aliquot of the samples 
was used to determine the turbidity, and the remaining solution was analyzed by  
nondenaturing PAGE to determine the size of the lipoproteins. No discoidal 
lipoprotein complexes were detected by electrophoresis for oxidized H1-H5 and 
H3-H4 mutants (Figure-13B), confirming the lack of activity of the mutants H1-
H5 and H3-H4 observed in the kinetics. However, after 24 h of incubation, a 
nearly complete clearance of liposomal turbidity was observed with the disulfide 
mutant L2-L4, and analysis of the samples by gradient gel electrophoresis 
confirmed the ability of the L2-L4 mutant to form lipoprotein complexes. The 
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lipoproteins obtained with this mutant were slightly larger than those obtained 
with the wild-type protein (Figure-13B, lanes 7 and 8). 
 
Interaction of ApoLp-III Disulfide Mutants with Preformed Discoidal DMPC 
Micelles-ApoLp-III mutants were allowed to interact with preformed mixed 
micelles of DMPC and Na+-cholate, and their ability to lead to the formation of 
discoidal lipoproteins upon removal of the detergent was investigated. The H1-
H5 mutant was the only inactive protein in the disulfide state. The disulfide 
mutants H3-H4 and L2-L4 promoted the formation of lipoprotein particles. The 
lipoproteins formed were characterized by their size (Figure-14) and density 
(Figure-15). The comparison of the sizes of the lipoprotein complexes obtained 
with the mutants H3-H4 and L2-L4 in both oxidized and reduced states shows  
FIGURE-13: Spontaneous interaction of 
apoLp-III with multilamellar liposomes.
(A) The kinetics of formation of discoidal 
lipoproteins was studied using aprotein to 
DMPC molar ratio of 1:20. The assay was 
performed at 23.9 °C for 30 min time 
period with 4 íM apoLp-III; (B) 
Nondenaturing 4-20% gradient PAGE of 
lipoprotein complexes obtained upon 24 h 
incubation of apoLp-III mutants (45µM) 
with DMPC: lane 1, high range molecular 
weight markers (Pharmacia); lane 2, wild-
type; lane 3, oxidized H1-H5 mutant; lane 
4, reduced H1-H5 mutant; lane 5, oxidized 
H3-H4; lane 6, reduced H3-H4; lane 7, 
oxidized L2-L4; and lane 8, reduced L2-
L4. The numbers on the left side of the 
figure indicate the apparent diameters, in 
nanometers, of the markers loaded in lane 
1. 
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that in the oxidized state the mutants produce larger lipoprotein particles than the 
wild-type protein. In the reduced state, these two mutants and the wild-type 
protein formed similar lipoproteins (Figure-14). 
The density of the lipoproteins formed and the fraction of unbound apolipoprotein 
were studied by ultracentrifugation in a KBr density gradient. At a protein to 
DMPC molar ratio of 1:60, wild-type apoLp-III forms lipoprotein complexes with 
an average density of 1.135 g/cm3 (Figure-15). The samples prepared with 
FIGURE-14: Interaction of ApoLp-III 
disulfide mutants with Cholate/DMPC 
mixed micelles. Nondenaturing PAGE of 
the lipoproteins prepared using a 1:60:60 
protein/DMPC/cholate molar ratio: lane 1, 
high range molecular weight markers; lane 
2, wild-type; lane 3, oxidized H3-H4; lane 
4, reduced H3-H4; lane 5, oxidized L2-L4; 
and lane 6, reduced L2-L4. The numbers 
on the left side of the figure indicate the 
apparent diameters, in nanometers, of the 
markers loaded in lane 1.
d (g/mL)
FIGURE-15: Interaction of 
ApoLp-III disulfide mutants with 
Cholate/DMPC mixed micelles. 
The density of the lipoprotein 
complexes and the presence of 
lipid-free (unbound) apoLp-III were 
studied by KBr density gradient 
ultracentrifugation. The 
lipoproteins were obtained using 
an initial protein/DMPC/ cholate 
molar ratio of 1:60:60. 
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oxidized H3-H4 and L2-L4 mutants form lipoprotein complexes with average 
densities of 1.105 g/cm3. The lower density of the lipoprotein complexes obtained 
with the disulfide mutants is consistent with the fact that 30% of the protein 
remains in the lipid-free state accumulating at the bottom of the gradient. On the 
other hand, ultracentrifugation of the samples prepared with the H1-H5 mutant 
(oxidized state) indicated that 100% of the apolipoprotein is in the lipid-free state 
and found in the bottom half of the gradient (Figure-15). 
On reducing the disulfide bonds, the density of the disks formed by the 
mutants is restored to the wild-type density of 1.13 g/mL (data not shown). 
In Vivo Lipid-Binding Activity of ApoLp-III Disulfide Mutants-The 
hemolymph of adult M. sexta insects contains 1-1.5 mg of apoLp-III, which is 
found in the lipid-free form and bound to lipophorin particles of different density. 
Ultracentrifugation of the hemolymph in KBr density gradient readily separates 
lipid-free apoLp-III, which accumulates at the bottom of the gradient, from 
lipophorin-bound apoLp-III, which is distributed between HDLp and LDLp 
subspecies and found in the top-half of the gradient (59). ApoLp-III molecules 
from M. sexta and L. migratoria insects share identical functions (64) and 
structures (8). We have recently shown that wild-type L. migratoria apoLp-III 
injected into the circulation of M. sexta insects binds to the insect lipoproteins 
with an affinity similar to that of the endogenous, native, apoLp-III (74).  
To study the in vivo lipid-binding activity of the disulfide mutants, we have 
compared the distribution of apoLp-III mutants between the lipid-free and the 
lipoprotein-bound fractions of the hemolymph with the distribution of wild-type 
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locust apoLp-III. Figure-16 shows the distribution of wild-type L. migratoria 
apoLp-III and the disulfide mutants H1-H5, H3-H4, and L2-L4 among the 
lipoprotein-bound and lipid-free fractions of the M. sexta hemolymph. A simple 
inspection of Figure-16 shows major differences between the distribution of the 
wild-type protein, 45% of which is associated to lipoproteins (LDLp + HDLp 
fractions), and the distributions of the disulfide mutants H1-H5 and H3-H4, for 
which the fraction of lipoprotein bound apoLp-III represents only ~5%. These 
results indicate that the disulfide bonds tethering α-helices 1 and 5, or 3 and 4, 
inactivate apoLp-III. On the other hand, the L2-L4 mutant is distributed among 
the lipoprotein bound (36%) and lipid-free forms in a fashion similar to the wild-
type protein indicating that tethering of the loops 2 and 4 has a minor impact on 
the lipid-binding activity of apoLp-III. 
 
The distribution of L. migratoria apoLp-III mutants among the density 
fractions of M. sexta hemolymph was determined by Western blotting as 
indicated in the Experimental Procedures. The hemolymph was separated into 
four density fractions by ultracentrifugation in a KBr gradient; pool 1(P1): LDLp 
FIGURE-16: In vivo binding of Locusta 
migratoria ApoLp-III disulfide mutants to 
Manduca sexta lipophorin. 
53
(low-density lipophorin, δ < 1.06 g/cm3); pool 2 (P2): HDLp (1.06 < δ < 1.12 
g/cm3); pool 3 (P3) and pool 4 (P4) contain lipid-free proteins (δ > 1.12 g/cm3). 
For the sake of clarity, a summary of the activity of the disulfide mutants of 
apoLp-III observed in different lipid-binding assays is shown in Table-3.
Table-3: Summary of Lipid-Binding Activity of the Disulfide Mutants of Apolipophorin-III 
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Discussion 
The association of apolipoproteins with the lipid surface of lipoproteins and 
membranes may involve several steps. Among the possible steps, we could 
distinguish adsorption of the protein to the lipoprotein lipid surface, insertion into 
the phospholipid monolayer, or bilayer, and one or more conformational changes 
that would be required to achieve the extended protein conformation of the final 
lipid bound state. The protein conformational changes required in different steps 
along the binding process are not known. Some of the conformational 
fluctuations available to the protein in the lipid-free state could be particularly 
important for the lipid-binding activity of the protein. For instance, concerted 
conformational fluctuations of one or more α-helices could be necessary for the 
initial interaction of the protein with the lipid surface or for the insertion of the 
protein into a phospholipid bilayer or monolayer. Other conformational changes 
may occur after an initial association of the apolipoprotein with the lipid surface. 
The role of the conformational flexibility in the lipid-binding activity of apoLp-III 
was investigated using three disulfide mutants, which introduced well-defined 
structural restrictions in different regions of the apoLp-III molecule. 
Differences between the Lipid-Binding Assays-Because the lipid-protein 
interaction is in general dependent on the physical and chemical nature of the 
lipid structure (76), the impact of the disulfide bonds on the lipid-binding activity 
of apoLp-III was studied in three different lipid-binding assays. The assays used 
imposed different restrictions to the lipid-binding activity of the protein providing 
additional information on the role of the conformational flexibility as well as on the 
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mechanisms of interaction. The spontaneous formation of lipoprotein particles 
upon interaction of the apolipoproteins with liposomes involves multiple steps 
including, among others, the insertion of the apolipoprotein into the bilayer and 
the breakdown of the large liposomal structures into small lipoprotein particles. 
On the other hand, the spontaneous association of apoLp-III with native spherical 
lipoproteins is limited by the ability of the protein to interact and become inserted 
into a spherical phospholipid monolayer. Finally, the interaction with discoidal 
micelles of DMPC overrides the initial steps of the lipid-protein interaction, such 
as the penetration of the protein or some of its R-helices in the lipid bilayer. In 
this assay, the protein activity would be limited by the ability of the protein to form 
a stable lipoprotein complex upon interaction with a lipid structure that is already 
small, discoidal, and has a preexposed hydrophobic surface around the bilayer 
disk (77). Thus, the interaction of apoLp-III with discoidal micelles of DMPC may 
not be impaired by the structural restrictions imposed by disulfide bonds to the 
extent that it impaired the interaction of the protein with a liposomal structure or 
with native lipoproteins. 
Conformational Flexibility of Helices 3 and/or 4 Is Necessary for the 
Insertion of ApoLp-III into the PhospholipidMonolayer of Spherical Native 
Lipoproteins- The role of the conformational flexibility of helices 3 and 4 in the 
lipid-binding activity of apoLp-III was investigated with the mutants H3-H4 and 
L2-L4. Both mutants effectively prevent the separation of helices 3 from 4 
(Figure-17). However, the disulfide present in the L2-L4 mutant tethers the N- 
and C-term residues of helices 3 and 4, respectively; therefore, it is expected to  
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reduce the conformational freedom of helices H3 and H4 to a lesser extent than 
the H3-H4 mutant, which tethers the centers of the helices.  
The inability of the oxidized H3-H4 mutant to interact spontaneously with 
DMPC vesicles, or in vivo, with native spherical lipoproteins suggests that the 
conformational flexibility of helices 3 and 4 is essential in the disruption of the 
packing of both phospholipid monolayers and bilayers. Two facts support this 
interpretation; in first place, the H3-H4 mutant forms discoidal lipoproteins upon 
incubation with discoidal micelles of DMPC and cholate, indicating that it can 
interact with disk bilayers when the acyl chains are preexposed. In second place, 
the fact that the loop mutant interacts spontaneously with MLV of DMPC as well 
as with native lipoproteins indicates that the greater flexibility of the helices H3 
and H4 tethered by the ends, as compared to the flexibility of the helices tethered 
by their centers, could be responsible of the lipid-binding activity observed in the 
FIGURE-17: Sketched 
representation of the extended 
conformations that could be 
adopted by different disulfide 
mutants in the lipid-bound 
state. 
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loop mutant. Because in a fully extended conformation both mutants could adopt 
similar structures (Figure-17), the activity of the loop mutant could not be 
explained by a difference in the stability of the lipid-bound state. This is also 
supported by the fact that H3-H4 and L2-L4 mutants lead to the formation of 
lipoproteins of similar properties when incubated with discoidal micelles (Figure-
14). Thus, these results suggest that the conformational flexibility of helices 3 
and/ or 4 is needed in the initial binding steps, including the insertion of the 
protein, or some of its regions, in phospholipid monolayers. For instance, as 
sketched in Figure-18B, unfolding of one of these helices could be required for 
the insertion of the protein into the phospholipid monolayer of native lipoproteins. 
Interaction of Loops 2 and 4 with the Lipid Surface Does Not Mediate 
Opening of the Helix Bundle of ApoLp-III- The presence of surface exposed 
nonpolar residues, and the conformational flexibility of the loop regions of apoLp-
III, have inspired models of apolipoprotein-lipid interaction in which the loops 
initiate the interaction with the lipid surface defect, and this interaction would, 
subsequently, trigger the opening of the helix bundle (6, 7). This type of 
mechanism was recently proposed on the basis of the conformational dynamics 
of loop 4, inferred from solution NMR studies (7). This model of interaction is 
represented in Figure-18A, and it suggests that loop 4 would initiate the 
interaction of apoLp-III with the lipoprotein surface leading to the separation of 
loops 2 and 4. The importance of this mechanism was tested in the present study 
by means of the L2-L4 mutant, which restricts the conformational flexibility of the 
loops and prevents the opening of the helix bundle through the separation of the  
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loops 2 and 4. As shown in the Results, this disulfide mutant was able to form 
discoidal lipoproteins upon interaction with either liposomes or discoidal micelles. 
Moreover, this mutant was able to interact with native spherical lipoproteins in a 
fashion similar to that observed with the wild-type apoLp-III. The fact that 
tethering of loops 2 and 4 does not affect the lipid-binding properties of apoLp-III 
in vivo indicates that the interaction of these loops with the lipoprotein lipid 
surface is not necessary for either the initial recognition of the lipoprotein lipid 
surface or for the opening of the helix bundle. It has also been proposed that 
FIGURE-18: Models of interaction of ApoLp-III with lipoprotein lipid surfaces. Two models of the 
initial apolipoprotein-lipid interaction steps are sketched: (A) recently proposed model of initial apoLp-
lipid interaction and opening of the helix bundle (Fan et al. (6)). In this model, the initial interaction of the 
loop 4 with the lipid surface would precede the opening of the helix bundle. (B) Alternative mechanism 
consistent with the observations made in the present study. In this model, the unfolding of helix 3 is 
involved in the initial insertion of the protein into the phospholipid structure. Similar models involving 
helix 4 or helices 3 and 4 simultaneously are also consistent with the results of this study. Helices 1 and 
5 could also be involved in the initial steps of the lipid-protein interaction. However, because the 
disulfide mutant tethering helices 1 and 5 is inactive, our study provided no information on this regard.
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interaction of loops 1 and 3 with the lipid surface would trigger an opening of the 
helix bundle (6). This hypothesis was tested in M. sexta apoLp-III, which has a 
similar structure to L. migratoria apoLp-III, by means of a disulfide mutant that 
was predicted to tether loops 1 and 3 (52). Interestingly, tethering of loops 1 and 
3 did not prevent apoLp-III from interacting spontaneously with liposomes leading 
to the formation of discoidal lipoproteins. Therefore, it would appear that the 
interaction of the loops with the lipid surface is not necessary for either the initial 
recognition of the lipid surface or for the opening of the helix bundle. 
Helices 1 and 5 Play a Major Role in the Stability of the Lipid-Bound State- 
We have recently shown that the conformational flexibility of helices 1 and 5 is 
required for the spontaneous interaction of apoLp-III with liposomes of 
phosphatidylcholine (73). In the current study, we have investigated further the 
role of helices 1 and 5 through the study of the interaction of the H1-H5 mutant 
with mixed discoidal micelles of DMPC and cholate and native spherical 
lipoproteins in vivo. The fact that this mutant does not associate with native 
spherical lipoproteins in vivo suggests that helices 1 and/or 5 could play an 
important role in the insertion of apoLp-III into the phospholipid monolayer of 
spherical lipoproteins. However, the fact that this mutant cannot form discoidal 
lipoproteins even upon interaction with discoidal micelles indicates that the 
conformational freedom of helices 1 and/or 5 is essential to achieve a strong 
lipidprotein interaction and thus for the formation of stable lipoprotein complexes. 
Although helices 1and 5 play a major role in stabilizing the lipid-bound state, our 
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results do not discard the involvement of these helices in the insertion of the 
protein in phospholipid monolayers and/or bilayers. 
Multiple Lipoprotein-Bound Conformations of ApoLp-III-The preferred 
conformation of apoLp-III in discoidal lipoproteins appears to be one where the 
polypeptide chain adopts a fully extended conformation around the periphery of 
the disk bilayer (16, 78, 79). Because of the restriction imposed by the disulfide 
bond, none of the disulfide mutants used in this study could adopt such a 
conformation (Figure-7). Therefore, the ability of the L2-L4 and H3-H4 mutants 
to form discoidal lipoproteins indicates that other apolipoprotein conformations 
are compatible with the formation of stable discoidal lipoproteins. Recent studies 
of human apoA-I in discoidal lipoproteins provided evidence consistent with the 
presence of multiple apolipoprotein conformations, including variable 
apolipoprotein arrangements (28, 80). Two lipid-bound conformations of apoE 
were also inferred in a recent study with reconstituted spherical lipoproteins (81). 
The present study provides strong evidence indicating that multiple 
apolipoprotein conformations, or alternative conformations, are possible not only 
in discoidal lipoproteins but also in spherical native lipoproteins. This is supported 
by the fact that the L2-L4 mutant has an in vivo lipid-binding activity similar to that 




LIPID-BOUND CONFORMATION OF HUMAN APOLIPOPROTEIN AI 
INTRODUCTION 
An inverse correlation exists between the circulating levels of high density 
lipoprotein (HDL) in human circulation and coronary heart diseases (CHD) (82-
85). Approximately 50% w/w of a HDL molecule is protein and apolipoprotein AI 
(apoAI) is the major protein associated with HDL(86). HDL molecules in the 
circulation are highly heterogeneous (20, 87) and can exist as large spherical 
HDL and small discoidal HDL particles.  The small discoidal HDL molecules are 
efficient in removing cholesterol from peripheral tissues (22). HDL bound apoAI 
mediates cholesterol efflux from peripheral tissues and activation of cholesterol 
esterification enzyme lecithin-cholesterol acyl transferase (LCAT), two essential 
steps in the process of reverse cholesterol transport and prevention of CHDs (19, 
21, 36, 68, 88). To better understand the physiology of lipid-bound apoAI it is 
essential to elucidate the structure of apoAI molecules in the lipid-bound state. 
Until recently, attempts to solve the lipid-bound conformation of exchangeable 
apolipoproteins have been by X-ray diffraction at 8 Å resolution (89, 90). The lack 
of high-resolution X-ray diffraction data of lipid-bound apolipoproteins can be 
attributed to the difficulties in obtaining diffraction quality lipoprotein crystals. This 
lack of high resolution structure of lipid-bound apoAI has been a major 
impediment in apoAI structure-function research. Novel technique utilizing 
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chemical cross-linking with a fixed arm length cross-linker coupled with 
mass spectrometry provides distance constraint data which aid in elucidating the 
low-resolution three-dimensional conformation of proteins (91-98). Discoidal HDL 
particles containing two molecules of apoAI can be easily reconstituted and 
owing to the physiological significance of these discoidal lipoprotein particles in 
reverse cholesterol transport (RCT) understanding the conformation of apoAI 
molecules in discoidal lipoproteins is relevant.  Recently the lipid-bound 
structures of apoAI bound to reconstituted discoidal lipoprotein molecules have 
been studied utilizing chemical cross-linking and mass spectrometry (29-31). 
Some advance has been made in identifying potential cross-links and the data till 
date suggest two adjacent apoAI molecules to be organized in an anti-parallel 
fashion on the periphery of discoidal lipoprotein surface forming a belt.  
To further elucidate the organization of two adjacent apoAI molecules, 
bound to discoidal lipoprotein surface using the chemical cross-linking coupled 
with mass spectrometry in this study we prepared rHDL molecules with a mixture 
of wild-type apoAI and 15N labeled recombinant apoAI molecules. The presence 
of 2 different types of apoAI molecules that could be distinguished by mass 
spectrometry makes the identification of intramolecular and intermolecular cross-
links less ambiguous. To identify potential interactions between adjacent lipid-
bound apoAI molecules in this study we have used chemical and enzymatic 
cleavage methods and tried to identify the resulting peptides by MALDI-TOF 
mass spectrometry. The drawbacks associated with using the chemical cross-
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linking and mass spectrometry strategy to solve the conformation of proteins and 




Purification of human Apolipoprotein AI from HDL (14N ApoAI)-HDL (d = 
1.21 – 1.06 g/mL) was isolated from plasma by sequential KBr density 
ultracentrifugation as described earlier (99). Frozen human plasma was obtained 
from Oklahoma Blood Institute (Oklahoma City, OK). The plasma was thawed at 
room temperature and the density (d) of the plasma was adjusted to 1.35g/mL by 
adding dessicated KBr. 8.0mL of plasma (d= 1.35g/mL) was transferred to 
25.0mL Ti-70 ultracentrifuge tube. The plasma was then layered with successive 
layers of KBr solution prepared in saline (1.1% NaCl and 0.1% Na2EDTA). First 
the plasma was layered with 7.0mL of d=1.21 g/mL KBr solution. Next the d=1.21 
g/mL layer was overlaid with 6.0 mL d=1.06 g/mL KBr solution. The top of the 
gradient was layered with 2.0mL saline and the tubes were centrifuged at 55,000 
rpm at 5˚C for 4 hours in a Ti-70 rotor. After centrifugation the tubes were 
fractionated into 3 mL fractions and the density of the fractions determined by 
standard refractometry. For second centrifugation the fractions with densities 
between 1.09-1.15 g/mL were pooled and the density adjusted to 1.26g/mL by 
adding dessicated KBr. 6.0mL of d=1.26 g/mL pool was layered in the bottom of 
Ti-70 ultracentrifuge tubes and successively layered with 8.5mL d=1.20 g/mL KBr 
solution, 4.0mL of 1.06 g/mL KBr solution and 2.0 mL of saline. The second 
centrifugation was performed under similar conditions as the first centrifugation. 
The tubes were fractionated into 3.0 mL fractions. Aliquots (200 µL) of the 
fractions from the second centrifugation were dialyzed against 50mM phosphate 
buffer for SDS-PAGE. Based on the SDS-PAGE fractions containing apoAI and 
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apolipoprotein AII (apoAII), corresponding to HDL was pooled. The isolated HDL 
was freeze dried and proteins delipidated by acetone precipitation. Following 
acetone precipitation the pellet was suspended in 50mM sodium phosphate, 3M 
guanidine hydrochloride pH 7.5, applied to a pre-equlibrated Sephacryl S-300 
gel-filtration column (Amersham Bioscience, Piscataway, NJ) and eluted at a 
flow-rate of 0.4 mL/min. Eluted sephacryl-S300 fractions corresponding to apoAI 
as determined by SDS-PAGE were pooled, dialyzed against 10mM ammonium 
bicarbonate buffer, lyophilized, resuspended in 3M guanidine hydrochloride and 
stored at -20˚C. Before use the apoAI stock was dialyzed against 50mM sodium 
phosphate, 150 mM NaCl, pH 7.4 (phosphate buffer). 
Expression and purification of recombinant 15N labeled apoAI fusion 
protein-pET30 vectors containing wild-type apoAI construct with a 6 kDa, 51 
residue fusion protein tag (containing 6 His residues) were transfected into BL-21 
E.coli expression hosts. Transfected cells were grown in M9 media 
supplemented with 15N labeled ammonium chloride (Cambridge Isotope 
laboratories, Andover, MA). The expression of apoAI was induced by the addition 
of IPTG to a final concentration of 1mM. IPTG induced cells were pelleted by 
centrifugation at 9000g for 10 min. at 4˚C. The pellet was lysed by adding 
lysozyme and deoxycholate. The lysate was centrifuged at 45,000 rpm for 1 hour 
in a Ti-75 rotor (Beckmann) to remove cell debris. Following ultracentrifugation 
the apoAI fusion protein was purified from the supernatant by standard nickel 
affinity chromatography. The purification was monitored by SDS-PAGE. 
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Estimating The Peptide Masses of Human ApoAI and 15N labeled 
Recombinant ApoAI Fusion Protein - Peptide mass fingerprinting of human apoAI 
(14N apoAI) and 15N labeled apoAI fusion protein (15N apoAI-FP) tryptic peptides 
was performed to estimate the sequence coverage in the mass spectra and the 
extent of 15N labeling efficiency of 15N apoAI-FP. 5µg each of purified 14N apoAI 
and 15N apoAI-FP was separated by SDS-PAGE and visualized by coomassie 
staining. The bands corresponding to 14N apoAI and 15N apoAI-FP were excised, 
minced and destained extensively in 50% acetonitrile, 25mM ammonium 
bicarbonate pH 8.0. The destained gel pieces were dehydrated in a speed 
vacuum concentrator. The dried gel pieces were rehydrated with 15µL
0.016ng/µL (~ 1:20 w/w trypsin: protein) sequencing grade trypsin (Promega) 
and incubated at 37˚C for 12 hours. After 12 hours of digestion the peptides were 
extracted with 3 30µL washes of 50% acetonitrile, 0.1% trifluroacetic acid (TFA) 
solution. 0.5µL of 14N apoAI or 15N apoAI-FP trypsin peptides was mixed with 
0.5µL of 5 mg/mL α-cyano-4-hydroxycinnamic acid (α-CHC) solution in 50% 
acetonitrile, 0.1% TFA and spotted on MALDI-TOF target plates. The mass 
spectra were acquired in a Voyager-DE Pro (Applied Biosystems, Foster City, 
CA) mass spectrometer, in the reflectron mode with acceleration at 20,000 V, 
delay time of 350 nsec and mass range of 500-3000 m/z. The acquired spectra 
were externally calibrated using peptide calibration mixture containing des-Arg1-
Bradykinin (m/z = 904.47), Angiotensin I (m/z = 1296.69), Glu1-Fibrinopeptide B 
(m/z = 1570.68), ACTH clip 1-17 (m/z = 2093.087) and ACTH clip 18-39 (m/z = 
2465.20) as external calibrants.  
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Preparation of 96Å rHDL particles- Reconstituted high density lipoprotein 
(rHDL) was prepared by cholate dialysis method (55), at protein to phospholipid 
(1-palmitoyl 2-oleyl phosphatidylcholine, POPC) ratio of 1:90 (mol/mol). POPC 
stock in chloroform was dried under N2 gas and reconstituted in phosphate 
buffer. Sodium cholate was added to the preparation at a final POPC to sodium 
cholate ratio of 1:1.5 (mol/mol) and incubated at 37˚C for 1 hour. The protein was 
added to the POPC-cholate mixture and incubated at 37˚C for 45 min. After the 
incubation period sodium cholate was removed by extensive dialysis against 4 
liters phosphate buffer over 36 hours at 25˚C with changes to fresh buffer 
solution every 8 hours. The rHDL was prepared with either 14N apoAI only, 15N
apoAI-FP only or a mixture of 1:1 molar ratio of 14N apoAI and 15N apoAI-FP as 
protein component.  
The 14N apoAI, 15N apoAI-FP, 14N apoAI/15N apoAI-FP containing rHDL 
particles prepared by cholate dialysis were purified by size exclusion 
chromatography in a Superose6 gel filtration column (Amersham Biosciences, 
Piscataway, NJ) to isolate rHDL particles of homogeneous size (96Å particles). 
The homogeneity of the purified rHDL particles was assessed by non-denaturing 
gradient gel electrophoresis (NGGE). 
Cross-linking of apoAI bound to rHDL particles- Dithiobis(succinimidyl 
propionate) DSP (Pierce) was dissolved in dimethyl sulfoxide to a final 
concentration of 6.5 mg/ml and added within 5 min. of preparation to the rHDL 
samples (final apoAI concentration of 0.5 mg/mL or lesser in phosphate buffer). 
96Å rHDL particles containing 14N apoAI, 15N apoAI-FP or 14N apoAI/15N apoAI-
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FP were cross-linked with DSP at 1:10 protein to DSP molar ratio for 30 min. at 
25˚C. The reaction was quenched by adding 1 M Tris-HCl, pH 7.5 to a final 
concentration of 0.1 M Tris-HCl. After quenching the samples were dialyzed 
against 4 L 25 mM ammonium bicarbonate pH 8.0 for 8 hours at 4˚C to remove 
the excess cross-linker. After dialysis the cross-linked apoAI monomer, dimers 
and higher order cross-linked apoAI molecules were separated by (i) SDS-PAGE 
or urea SDS-PAGE and (ii) size-exclusion chromatography. Separation in urea 
SDS-PAGE gel was performed to resolve anomalous mobility of cross-linked 
apoAI molecules in a SDS-PAGE gel without urea (31).  
In-gel Trypsin digestion- Coomassie blue stained protein bands 
corresponding to  14N apoAI  or 15N apoAI-FP  monomers or dimers  and 14N
apoAI/15NapoAI-FP heterodimers separated by SDS-PAGE were digested with 
trypsin as described earlier. The types of cross-linked samples used for in-gel 
digestion and MALDI-TOF mass spectrometry are listed in Table-4.
rHDL prepared with PMF for sample type
14N apoAI control
14N apoAI DSP modified monomer
14N ApoAI only 
14N apoAI homodimer
15N apoAI-FP monomer (control)
15N apoAI-FP DSP modified monomer
15N ApoAI-FP only 
15N apoAI-FP homodimer
14N DSP modified monomer
15N apoAI-FP DSP modified monomer
14N apoAI homodimer
14N apoAI:15N apoAI-FP heterodimer
1:1 14N apoAI and 15N apoAI-FP (mol/mol) 
15N apoAI-FP homodimer
Table-4: Types of cross-linked samples used for in-gel digestion and PMF. The samples were 
assigned as monomer or dimer based on their relative mobility (molecular weight estimates) in SDS-PAGE. 
 
MALDI-TOF mass spectrometry of trypsin digests- The peptide masses of 
in-gel trypsin digested samples (listed in Table-4) was determined in a Voyager 
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DE-Pro MALDI-TOF mass spectrometer. The mass spectra were acquired in the 
reflectron mode in α-CHC matrix with acceleration of 20,000 volts, delay time of 
350 nsec under non-reducing conditions.  The acquired mass spectra were first 
externally calibrated with peptide calibration mixture. The externally calibrated 
spectra were then internally calibrated with unmodified 14N apoAI or 15N apoAI-
FP peaks as internal calibrants to ≤ 50ppm error.  
CNBr cleavage of 14N apoAI- Cross-linked 14N apoAI monomers and 
dimers were purified by gel-filtration chromatography. For gel-flitration the cross-
linked 14N apoAI rHDL was freeze dried and phospholipids removed by acetone 
precipitation. The pellet was resuspended in 50mM sodium phosphate, 150mM 
sodium chloride and 3M guanidine hydrochloride, pH 7.5 and loaded in a 
Sephacryl-S300 column equilibrated with the same buffer. The purification was 
assessed by SDS-PAGE. The fractions corresponding to cross-linked monomer 
and dimer were pooled and stored at -20˚C until further use.  
1mg each of control 14N apoAI, DSP cross-linked 14N apoAI monomer and 
dimer were cleaved with CNBr as described earlier (100). The control, DSP 
modified monomer and dimers were dialyzed against 5 mM ammonium 
bicarbonate buffer, pH 8.0 and dried in a vacuum concentrator. The dried 
samples were reconstituted in 70% TFA and transferred to glass vials. Two 
crystals of CNBr (Sigma) were added to each vial and the samples were 
incubated in dark at 37˚C for 24 hours. After the end of incubation the samples 
were dried in a vacuum concentrator to remove CNBr and TFA. The extent of 
CNBr cleavage was monitored by 16% tris-tricine SDS-PAGE and MALDI-TOF 
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mass spectrometry in the linear mode. CNBr cleaved apoAI fragments 
aggregated in aqueous buffer yielding a turbid solution. To prevent aggregation 
dried CNBr cleavage fragments were dissolved in 6M guanidine hydrochloride 
and stored at -20˚C until use. For MALDI-TOF analysis the CNBr fragments in 
6M guanidine hydrochloride was desalted by C4 Zip-tip® (Millipore, Billerica, MA) 
micro-chromatography and spotted on MALDI-TOF plates. The spotted samples 
were allowed to air-dry and overlaid with 1 µL 10 mg/mL Sinapic acid (Sigma) in 
50% acetonitrile, 0.1% TFA. The spectra were acquired in a Voyager DE-Pro 
MALDI-TOF mass spectrometer in the linear mode with accelerating voltage of 
25,000 V and a delay time of 600 nsec. The acquired spectra of 14N apoAI CNBr 
fragments were calibrated with unmodified 14N human apoAI (M+H)+1 and 
(M+2H)+2 ions (m/z 28079.62 and 14039.81 respectively) as external calibrants.  
To identify the CNBr cleaved peptides the peptides were purified by gel-filtration 
and reverse phase HPLC. Gel filtration was performed in a home made G-50 
superfine resin packed in a 50 cmx0.7 cm column and eluted with 25mM citrate 
buffer, 3M guanidine-hydrochloride pH 3.8 under non-reducing conditions. The 
reverse phase HPLC was performed in a C18 or C4 columns (Phenomenox, 
Torrance, CA) under oxidizing and reducing conditions. The bound CNBr 
peptides were eluted with a linear gradient (0-100%) of 80% acetonitrile, over 15 
min. For HPLC runs under reducing conditions to cleave the cross-linked 
peptides, dithiothreitol (DTT) was added to a final concentration of 25mM to the 
samples and elution solvents. 
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Peptide Mass Fingerprinting of CNBr fragments of DSP cross-linked apoAI 
dimers- CNBr fragments of lipid-free apoAI or DSP cross-linked apoAI dimers 
separated in 16% Tris-Tricine gels were identified by trypsin digestion and 
peptide mass fingerprinting. The isolated gel bands were digested with trypsin 




Protein Purification- 14N apoAI and 15N labeled apoAI-FP were purified to 
>95% homogeneity as observed in coomassie blue stained SDS-PAGE gels 
(Figure-19). 
 
Efficiency of In-gel Trypsin Digestion and 15N Labeling- The mass spectra 
of 14N apoAI and 15N apoAI-FP was compared against theoretical list of apoAI 
and 15N apoAI-FP m/z values obtained from online protein digestion software ‘MS 
Digest’ (University of California, San Fransisco). Wild-type apoAI has 37 possible 
trypsin cleavage sites (21 Lys residues and 16 Arg residues) distributed evenly 
along its sequence. The recombinant apoAI-FP has 42 trypsin cleavage sites (24 
Lys residues and 18 Arg residues). The additional 5 cleavage sites are located in 
the 6kDa fusion-protein tag of the recombinant apoAI. Under the trypsin cleavage 
conditions used the PMF data covered 87% and 89% 14N apoAI sequence and 
15N apoAI-FP respectively (Figure-20). ApoAI residues 174-206 (corresponding  
 
Figure-19: Coomassie blue stained 4-20% SDS-PAGE to monitor the purification of 14N apoAI  
and 15N labeled recombinant apoAI-FP. A, Shows purified 14N human apoAI (28.0 kDa).  B, 15N
labeled recombinant apoAI fusion protein (34.0 kDa) purified by Ni 2+ affinity chromatography. Lane 
1, lysate and lane 2, purified 15NapoAI-FP. 
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to residues 225-257 in apoAI-FP) and residues 14-43 in the fusion-protein 
sequence were absent in the peptide mass fingerprint data. Pilot in-gel trypsin 
cleavage experiments were carried out by varying the amount of trypsin and the 
incubation time but no further improvement in the sequence coverage was 
observed. 
15N apoAI-FP peptide mass fingerprint (Figure-21) was compared to a list 
containing the theoretical m/z of the 15N apoAI-FP tryptic peptides. The 
theoretical m/z of 15N apoAI-FP tryptic peptides was calculated by adding 1 Da  
 
(a) Human apoAI sequence (14N apoAI) 
 
10                     20                      30                     40                     50                         60  
DEPPQSPWDR VKDLATVYVD   VLKDSGRDYV  SQFEGSALGK  QLNLKLLDNW    DSVTSTFSKL  
 
70                       80                      90                     100                      110                   120  
REQLGPVTQE   FWDNLEKETE GLRQEMSKDL  EEVKAKVQPY  LDDFQKKWQE  EMELYRQKVE  
 
130                      140                    150                     160                    170                     180  
PLRAELQEGA   RQKLHELQEK   LSPLGEEMRD  RARAHVDALR  THLAPYSDEL   RQRLAARLEA
190                    200                      210                     220                   230                     240  




(b) Recombinant apoAI fusion protein sequence (15N apoAI-FP) 
 
10                       20                      30                       40                        50                    60  
MHHHHHHSSG LVPRGSGMKE  TAAAKFERQH MDSPDLGTDD DDKAMAHFWQ QDEPPQSPWD  
 
70                       80                        90                     100                    110                   120  
RVKDLATVYV   DVLKDSGRDY   VSQFEGSALG   KQLNLKLLDN WDSVTSTFSK   LREQLGPVTQ  
 
130                      140                    150                      160                    170                  180  
EFWDNLEKET  EGLRQEMSKD    LEEVKAKVQP YLDDFQKKWQ EEMELYRQKV EPLRAELQEG  
 
190                     200                       210                    220                    230                   240  
ARQKLHELQE   KLSPLGEEMR    DRARAHVDAL  RTHLAPYSDE  LRQRLAARLE  ALKENGGARL
Figure-20: Sequence coverage in peptide mass fingerprints of (a) 14N apoAI and (b) 15N
apoAI-FP. The underlined sequences were not observed in PMF under the trypsin cleavage 
conditions used.
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Figure-21: PMF of 14N apoAI and 15N apoAI-FP to estimate the 15N labeling efficiency by 
in-gel trypsin digestion and MALDI-TOF mass spectrometry. 15N apoAI-FP tryptic peptides 
show an increase in mass (+1 amu/N atom) on 15N labeling as compared to 14N apoAI 
peptides. For example, in the 14N apoAI PMF spectra 781.43 (m/z) maps to residues 154-160 
(sequence: AHVDALR; containing 12 N atoms) this corresponds to m/z 793.43 in 15N apoAI-FP 
sequence. The mass spectrum of 15N apoAI-FP indicates that the recombinant apoAI-FP was 
100% labeled with 15N apoAI. The peaks indicated with an asterix (*) were used as internal 
calibrants in future MALDI-TOF analyses.  
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for every nitrogen atom in the corresponding 14N tryptic peptides. Based on this 
analysis there was 100% 15N labeling of the apoAI-FP. 
Cross-linking of rHDL bound apoAI- 96Å rHDL particles containing 14N
apoAI, 15N apoAI-FP or 1:1 molar ratio of 14N apoAI: 15N apoAI-FP were purified 
to homogeneity by gel-filtration chromatography (Figure-22). The rHDL particles 
prepared with 14N apoAI, 15N apoAI-FP or 1:1 molar ratio of 14N apoAI: 15N apoAI-
FP did not show any difference in size.  
 
The cross-linked protein molecules were separated by non-reducing SDS-
PAGE (Figure-23). The results show that cross-linking of rHDL containing 14N
apoApoAI, 15N apoAI-FP yield 2 major bands corresponding to dimers and 
trimers (Figure 23, lanes 4-5) and minor higher order cross-links. While the DSP 
cross-linking of rHDL particles containing 1:1 ratio of 14N apoAI: 15N apoAI-FP did 
have cross-linked dimers and trimers or higher order cross-links (Figure 23, lane 
6) but were smeared and did not separate well in SDS-PAGE gels. The 
Figure-22: Coomassie Blue stained 4-20% non-
denaturing gradient gel to monitor purification of rHDL 
particles. 1:90 apoAI: POPC (mol:mol) rHDL particles 
purified by gel-filtration. Lane 1, rHDL containing 14N
apoAI, lane 2, rHDL containing 15N apoAI-FP and lane 3, 
rHDL containing 1:1 molar ratio of 14N apoAI : 15N apoAI-
FP.  
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estimated masses of the cross-linked apoAI molecules in Figure-23 are 
tabulated in Table-5.
Estimated Corresponds to possible  
116 14N tetramer 
72 14N trimer 
53 14N dimer 
Cross-linked 
14N ApoAI, 
Figure-3 lane 3 28 14N monomer 
147 15N tetramer 
90 15N trimer 
69 15N dimer 
Cross-linked 
15N ApoAI-FP, 
Figure-3, lane 4 37 15N monomer 
Table-5: Estimated masses of DSP cross-linked 14N apoAI and 15N apoAI-FP products based on 
relative mobility values (Figure-23).
To investigate the mobility of cross-linked apoAI molecules in the 
presence of urea in SDS-PAGE gels cross-linked 14N apoAI molecules were 
separated in 12% urea SDS-PAGE gels (Figure-24). The mobility of 72 kDa 
band corresponding to 14N apoAI trimer (Figure-6, Panel A, lane 4-5) shifts to 53 
Figure-23: Coomassie blue stained 4-20% 
non-reducing SDS-PAGE to separate DSP 
cross-linked products. Lane 1, Control rHDL 
containing 14N apoAI only; Lane 2, Control 
rHDL containing 15N apoAI-FP; Lane 3, Control 
rHDL containing 1:1 (mol/mol) 14N apoAI:15N
apoAI-FP; Lane 4, DSP cross-linked rHDL 
containing 14N apoAI only; Lane 5, DSP cross-
linked rHDL  containing 15N apoAI-FP; Lane 6,
DSP cross-linked rHDL containing 1:1 
(mol/mol) 14N apoAI:15N apoAI-FP.     
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kDa in the presence of 6M urea (Figure-24, Pane B, lane 2). This anomalous 
mobility is attributed to a cross-link between lys 118 and lys 140 in the central 
region of apoAI molecule (31). As reported earlier, this observation suggests the 
14N apoAI dimer to exist in 2 different conformations that migrate as 53kDa band 
corresponding to the theoretical mass of apoAI dimer and a second band which 
migrates with an apparent molecular weight of 72 kDa in SDS-PAGE gels. Cross-
linked rHDL molecules containing 15N apoAI-FP or 1:1 ratio of 14N apoAI: 15N
apoAI-FP was not characterized by urea SDS-PAGE.  
 
Estimating The m/z of Trypsin Digested control and cross-linked apoAI 
Peptides - 14N apoAI and 15N apoAI-FP have total of 37 and 42 possible tryptic 
peptides respectively. 12 14N apoAI peptides and 15N apoAI-FP peptides have 
Figure-24: 12% SDS-PAGE to investigate the anomalous mobility of DSP cross-linked 14N apoAI 
molecules in the presence and absence of 6M urea. Panel A, DSP cross-linked 14N apoAI molecules 
separated by 12% SDS-PAGE. Lane 1, Mark-12 molecular weight markers; lane 2, lipid-free 14N apoAI; 
lane 3, DSP cross-linked 14N apoAI products. Panel B, DSP cross-linked 14N apoAI molecules 
separated by 12% urea SDS-PAGE. Lane 1, lipid-free 14N apoAI; lane 2, DSP cross-linked 14N apoAI 
products. 
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m/z < 500 and were not observed in the mass spectra. The mass spectra were 
acquired in the range of m/z 500-3000. 
A list of masses (m/z) from the mass spectra of each sample listed in 
Table-4 was generated. The list was analyzed for the presence of unmodified 14N
or 15N apoAI peptides, DSP modified hanging ends, intrapeptide, intramolecular 
and intermolecular. The new peptide masses observed both in monomeric apoAI 
and in heterodimers or homodimers were treated as potential hanging ends, 
reduced hanging ends, intramolecular or intrapeptide cross-links. The reduced 
hanging ends must be absent in the mass spectra of cross-linked apoAI 
monomers and dimers which was acquired under oxidizing conditions. The 
structure of DSP, cross-linking reaction, the structures of the various DSP 
modifications and the associated mass increase are shown in Figure-25. DSP 
modified lysine residues are insensitive to trypsin digestion. In the identification of  
 
Figure-25: Structure of DSP, various types of DSP modifications and associated mass 
increase (Da). 
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cross-linked peptides it was assumed that the cleavages at cross-linked lysine 
residues were skipped. The new peptide masses (m/z) observed exclusively in 
the 14N apoAI homodimers, 15N apoAI-FP homodimers or 14N apoAI / 15N apoAI-
FP heterodimer bands were treated as potential intermolecular cross-links. The 
hanging ends, intrapeptide, intramolecular and intermolecular cross-links were 
identified by searching a theoretical list of all possible DSP cross-links of apoAI 
created in Excel spreadsheet program. The total number (175 m/zs) of new m/z 
observed in peptide mass fingerprint of various cross-linked apoAI molecules are 
tabulated in Table-6 of which 18 m/zs were identified as possible hanging ends 
or intrapeptide cross-links Table-7. The hanging ends and intrapeptide 
identifications in Table-7 are the only conclusive identifications, from the in-gel 
trypsin digestion experiments. Of the remaining 157 no further identifications as 
intramolecular or intermolecular cross-links could be made. 
Sample  # of new m/z observed in the peptide mass fingerprint 
14N apoAI DSP modified monomer 32 
14N apoAI DSP modified dimer 45 
15N apoAI-FP DSP modified monomer 31 
15N apoAI-FP DSP modified dimer 32 
14N apoAI and 15N apoAI-FP DSP modified 
heterodimer 35 
Table-6: Number of new m/z observed in peptide mass fingerprint of DSP modified apoAI molecules. 
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14N apoAI peptide sequence Lysine involved 
(A) Hydrolyzed hanging ends in 14N apoAI-FP 
1204.56 1204.57 8.30 1012.58  (207)AKPALEDLR(215)  208 
1603.67 1603.66 -6.24 1411.67  (107)KWQEEMELYR(116)  107 
1619.66 1619.65 -6.17 1427.66 
Oxidized 
methionine (107)KWQEEMELYR(116)  107 
1706.84 1706.80 -23.44 1514.81  (227)VSFLSALEEYTKK(239)  238 
2070.01 2070.03 9.66 1878.03  (11)VKDLATVYVDVLKDSGR(27)  12/23 
2073.95 2073.96 4.82 1881.97  (46)LLDNWDSVTSTFSKLR(61) 59 
2220.01 2220.03 9.01 2028.04   (189)LAEYHAKATEHLSTLSEK(206)  195 
(B) Intrapeptide crosslinks in 14N apoAI 
2052.00 2052.02 9.75 1878.03  (11)VKDLATVYVDVLKDSGR(27)  12-23 
2339.05* 2339.09 17.10 2165.11  (89)DLEEVKAKVQPYLDDFQK(106) 94-96 
2339.05* 2339.12 29.93 2165.14  (132)QKLHELQEKLSPLGEEMR(149)  133-140 
2383.12 2383.16 16.78 2209.18   (196)ATEHLSTLSEKAKPALEDLR(215)  206-208 
(C) Reduced crosslinks in 14N apoAI 
1605.70 1605.75 31.13 1517.75 Pyroglutamate (84)QEMSKDLEEVKAK(96) 88 or 94 
2753.36 2753.46 36.32 2665.47  
(172)QRLAARLEALKENGGARLAEYHAK 
(195)  182 
2. Identified DSP modified peptides in 15N apoAI-FP§
observed theoretical ppm error Residue# 
Chemical 
modifications 
15N apoAI-FP peptide sequence Lysine involved 
(A) Hydrolyzed hanging ends in 15N apoAI-FP 
1365.63 1365.62 -7.32 1173.63  (178)LEALKENGGAR(188)  182 
1619.69 1619.66 -18.52 1427.67  (107)KWQEEMELYR(116)  107 
1635.68 1635.65 -18.34 1443.66 
Oxidized 
methionine (107)KWQEEMELYR(116)  107 
2092.01 2092.03 9.56 1900.03  (11)VKDLATVYVDVLKDSGR(27)  12 or 23 
2095.95 2095.96 4.77 1903.97  (46)LLDNWDSVTSTFSKLR(61) 59 
2244.03 2244.03 0.00 2052   (189)LAEYHAKATEHLSTLSEK(206)  195 
(B) Intrapeptide cross-links in 15N apoAI-FP 
2074.02 2074.01 -4.82 1900.03   (11)VKDLATVYVDVLKDSGR (27) 12-23 
* The observed m/z matches to two possible cross-linked intrapeptide links 
§ The FP part of apoAI-FP has 51 residues, the fusion protein resiudes 1-51 are numbered from -51 to -1while the apoAI part 
are numbered form 1-243 
 
Table-7: Identification of DSP cross-linked peptides. A, hydrolyzed hanging ends in 14N apoAI; B, 
Intrapeptide cross-links in 14N apoAI; C, Hydrolyzed hanging ends in 15N apoAI-FP; and D, Intrapeptide 
cross-links in 15N apoAI-FP.     
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CNBr Cleavage of apoAI molecules- Pilot CNBr cleavage experiments 
were performed only with 14N apoAI molecules to optimize the cleavage and 
separation conditions. Cross-linked 14N apoAI dimers were purified by size 
exclusion chromatography (Figure-26). The cross-linked 14N apoAI dimers were 
purified to homogeneity as monitored by non-reducing 4-20% SDS-PAGE 
(Figure-26 inset).  The size of dimers purified by gel-filtration was estimated by 
MALDI-TOF mass spectrometry. Figure-27 shows the mass spectra of purified 
14N apoAI dimer. The (M+H)1+ ion (m/z = 58056.69) and (M+2H)2+ ion (m/z = 
29027.51) are present. In Figure-27 there are no peaks at m/z > 58056.69 this 
confirms the results from urea SDS-PAGE gels (Figure-24) that the72k Da band 
in the cross-linked 14N apoAI dimer to be due to conformational changes leading 
to differences in migration (Figure-23) of apoAI dimers in SDS-PAGE.  
The 16% tris-tricine SDS-PAGE (Figure-28) shows that under the CNBr 
cleavage conditions employed the control and DSP modified 14N apoAI 
molecules to yield major fragments corresponding to complete and partial CNBr 
cleavages. The only observable difference between the apoAI monomer and 
dimer in the 16% SDS-PAGE gel is the presence of a ~ 22kDa band in the 
dimers. This 22kDa band could be a cross-link between 2 N-terminal CNBr 
fragments (1-86 mass- 9870.95 Da) or 2 C-terminal CNBr fragments (149-243, 
mass-10725.27 Da) or between N (1-86, mass- 9870.95 Da) and C terminal 
(149-243, mass-10725.27 Da) CNBr fragments of apoAI molecule.  
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Figure-26: Coomassie blue stained 4-20% SDS-PAGE to monitor the purification of DSP 
cross-linked 14N apoAI by size-exclusion chromatography in sephacryl S-300 column. 
Fractions corresponding to dimers and monomers are labeled in the gel. 
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Sizes of CNBr cleaved control or DSP modified 14N apoAI were analyzed 
by MALDI-TOF mass spectrometer in the linear mode (Figure-29). Based on the 
 
Figure-27: Estimating the size of 14N apoAI dimer by MALDI-TOF mass spectrometry. Purified 14N
apoAI dimers were analyzed in the linear mode in a Voyager DE-Pro MALDI-TOF mass spectrometer. 
The spectra were acquired with sinapic acid matrix at accelerating voltage of 25,000V and delay time of 
600 nsec. The acquired spectra were calibrated (200ppm error) with unmodified 14N human apoAI MH+1 
ion (m/z 28079.62) as external calibrant.  
Figure-28: 16% Tris-Tricine SDS-PAGE to characterize 
the CNBr cleavage of 14N apoAI monomer and dimer. 
The difference between the CNBr cleavage fragments of 
apoAI monomer and dimer is a ~ 22kDa band (indicated by 
an arrow) which is present in the dimer but not in the 
monomer. 
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mass spectra, only the complete cleavage fragments of apoAI were observed. 
The CNBr fragments from DSP cross-linked 14N apoAI monomer or dimer did not 
yield good mass spectra in MALDI-TOF.  Due to the lack of mass spectra for the 
CNBr peptides of cross-linked apoAI dimers the identity of the CNBr peptides in 
the dimers could not be established and the new 22 kDa peptide in the 16% Tris-
Tricine gel could not be mapped to any specific region of apoAI.   
The CNBr cleavage fragments of control 14N apoAI molecules were purified by 
gel-filtration and reverse phase HPLC. The purification by both methods was 
monitored by 16% tris-tricine SDS-PAGE electrophoresis (Figure-30 a and b). 
Fractions from C4 reverse phase HPLC separation of CNBr fragments of DSP 
cross-linked 14N apoAI dimers were separated in 16% Tris-Tricine SDS-PAGE 
(Figure-30c). Based on the SDS-PAGE the separation of CNBr fragments of 
Figure-29: Estimating the masses of CNBr fragments of 14N apoAI by MALDI-TOF mass 
spectrometry. The four peaks show in the mass spectra corresponds to the complete CNBr cleavage 




























apoAI monomers or dimers could not be achieved by gel filtration or reverse 
phase HPLC. To improve the separation of the CNBr peptides in C4 columns the 
solvent in the organic phase was changed form acetonitrile to more hydrophobic 
isopropanol (70% isopropanol : 20% acetonitrile in water) but still no good 
separation could be achieved (data not shown). This could be due the fact that 
the hydrophobic CNBr peptides of apoAI bind strongly with the C4 or C18 
reverse phase matrix and are insensitive to the organic solvent gradient. This will 
lead to the elution of all the CNBr peptides together at 100% concentration of the 
organic phase.  
To map the CNBr fragments to apoAI sequence the bands from the 16% 
Tris-Tricine gels (Figure-30b and c) were digested with trypsin and the peptide 
mass fingerprint was acquired in MALDI-TOF mass spectrometer. The tryptic 
peptides generated from the CNBr fragments of apoAI mapped to all regions of 
intact apoAI and we were unable to assign the CNBr fragments to the 
corresponding regions in apoAI sequence. The ambiguity in the peptide mass 
fingerprinting data can be explained by considering the sizes of apoAI CNBr 
fragments. The theoretical masses of complete CNBr cleavage fragments of 
apoAI are 9870.95 Da (1-86), 3164.55 Da (87-112), 4228.81 Da (113-148) and 
10725.27 (149-243). The partial cleavage fragments of apoAI will have 
approximately similar masses and cannot be separated by SDS-PAGE. For 
example a partial cleavage fragment consisting of apoAI residues 1-148 (17.3 
kDa) and 87-243 (18.2 kDa) will have masses very similar and cannot be 
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separated by SDS-PAGE. So an 18kDa band in SDS-PAGE gel from CNBr 
cleavage of apoAI will yield the PMF of intact apoAI molecule.  
 
Figure-30: Purification of CNBr peptides of 14N apoAI monomers and cross-linked dimers. (a) 
Separation of apoAI monomer CNBr peptides by gel-filtration chromatography; (b) Separation of apoAI 
monomer CNBr peptides reverse phase HPLC in C4 column; and (c) Separation of cross-linked apoAI dimer 




An interesting feature of the cross-linking and MALDI-TOF analysis in this 
study is that all the identified cross-links were either hanging ends or intrapeptide 
cross-links only. No cross-links between lysines in two different apoAI tryptic 
peptides (cross-linked dipeptides) could be identified. The inability to identify 
intramolecular or intermolecular cross-links could be due to various reasons.  
Cross-linking at residues other than lysine- Imidoester chemical cross-
linkers have been shown to cross-link at residues other than lysines (101). Serine 
and tyrosine residues are most commonly observed to be cross-linked by 
imidoester cross-linkers like DSP, which was used for cross-linking in this study. 
The cross-linking at resiudes other than lysines is a possibility because we were 
unable to identify more than 90% (157 m/z) of the new m/zs observed. To 
exclude the possibility of DSP cross-linking at residues other than lysines (at 
serine and tyrosine residues) the new m/zs from the cross-linking of DSP was 
compared to a new list containing a list of possible cross-links at lysine, serine 
and tyrosine residues, but no new identifications could be made.   
Inability of cross-linked dipeptides to ionize in MALDI-The tryptic peptides 
of cross-linked apoAI molecules were ionized in the reflectron mode in MALDI-
TOF in the mass range of 500-3000 Da. There is a possibility that the cross-
linked peptides are larger than 3000Da and are not observed under the 
conditions used. To rule out this possibility the peptide mass fingerprint of the 
cross-linked apoAI molecules was also acquired in the linear mode in the mass 
range of 4000-10,000 Da. The data acquired in the linear mode did not lead to 
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the identification any new intra or intermolecular cross-links. This suggests that 
cross-linked apoaI dipeptides do not ionize efficiently in MALDI. The other 
observation in this study also supports this possibility, the CNBr cleaved control 
apoAI molecules did yield good mass spectra but we were able to identify the 
complete CNBr cleavage fragments from DSP cross-linked 14N apoAI dimer 
samples in MALDI-TOF.  
Decay of cross-linked apoAI molecules-There is a total of 175 new m/zs in 
cross-linked apoAI samples. But we were able to identify only 18 of the 175 new 
m/z. In-source fragmentation of cross-linked apoAI molecules could lead to the 
fragmentation of apoAI peptides leading to the generation of m/zs which are 
significantly different than the expected m/z.  We believe that such in-source 
decay could be hampering the positive identification of intramolecular and 
intermolecular links during MALDI. Moreover peptides in MALDI have been 
reported to spontaneously fragment in source (102-104). Spontaneous 
fragmentation of peptides at Asp-Pro, Asp-X and Glu-X bonds has been 
observed during MALDI (105, 106). ApoAI has 16 Asp and 30 Glu residues. This 
high abundance of acidic residues in apoAI could possibly lead to spontaneous 
fragmentation of cross-linked inter and intramolecular molecules during MALDI 
leading to the generation of unexpected m/z in the mass spectra and 
complicating the interpretation of data. The inability to identify more than 90% of 
the new m/zs generated after cross-linking strongly suggests in-source 
fragmentation of apoAI peptides leading to the generation of peptide fragments 
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which do not match with the expected theoretical masses of cross-linked apoAI 
peptides.   
In the three recent reports (29-31), reconstituted discoidal HDL (96 Å diameter) 
molecules containing 2 apoAI molecules were cross-linked with lysine reactive 
homobifunctional cross-linker (12 Å spacer arm) Dithiobis succinamidyl 
propionate (DSP) or Bis(sulfosuccinimidyl)suberate (BS3). Cross-linked apoAI 
dimers were purified and digested with trypsin and the resulting peptides were 
identified by electrospray ionization mass spectrometry (ESI MS) and MS/MS 
fragmentation. The intrapeptide, intramolecular and intermolecular cross-links 
identified by mass spectrometry from the three reports are summarized in Table-
8 a to c. Table-1 a to c displays very few identifications that are common 
between the three reports (Figure-31). An ideal intermolecular cross-link is not 
ambiguous if the identified cross-link is between two lysines at the same position 
or between lysines in 2 peptides corresponding to the same region in adjacent 
apoAI molecules and the masses corresponding to intermolecular cross-links is 
present only in the peptide mass finger print (PMF) of cross-linked dimer. Such 
unique intermolecular cross-links are present in the reported data but there are 
also other intermolecular cross-links that are between lysines corresponding to 
different regions of apoAI molecule. In the two reports by Davidson et al, the 
intermolecular cross-links were assigned by an indirect method, by considering 
the peak intensities in ESI-MS spectra. If the ratio of any cross-linked peak 
intensity in dimer to monomer was greater than 1.7 then the peak was identified 
as an intermolecular cross-link and if the ratio was lesser than 1.7 then the peak 
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was identified as an intramolecular cross-link.  Overall the assignments of 
intermolecular cross-links in the published reports are few and ambiguous. 
Moreover, in the three reports the possibility of unexpected cross-linked products 




ApoAI Peptide Cross-linked lysines Observed (Da) Theoretical (Da)
84-96 K88-K94 1707.75 1707.76
11-27 K12-K23 2051.01 2051.01
132-149 K133-K140 2338.11 2338.11
189-215 K195-(K206 or K208) 3386.56 3386.52
Davidson, 2005
84-96 K88-K94 1671.84 1671.84
95-107 K96-K106 1716.91 1716.92
11-27 K12-K23 2015.10 2015.11
227-243 K238-K239 2108.11 2108.12
89-106 K94-K96f 2302.16 2302.18
132-149 K133-K140g 2302.20 2302.20
196-215 K206-K208 2346.25 2346.26
28-59 K40-K45 3728.04 3728.22
Bhat, 2005
11–27 12–23 2051.01 2051.01
84–96 88–94 1707.75 1707.75
89–106 94–96 2338.09 2338.08
132–149 133–140 2338.11 2338.13
Table-8: Cross-linked apoAI 
peptides identified in 
published reports . Identified 
(a), intrapeptide; (b), 
intramolecular; and (c), 
intermolecular cross-linked 
apoAI peptides by mass 
spectrometry in published 
reports. The report by Davidson 
et al, 2003 was not supported 
by MS/MS fragmentation data.  
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(b) 
Published Intramolecular cross-links 
Davidson, 2003 
Peptide-I Peptide-II Cross-linked lysines Observed (Da) Theoretical (Da) 
239-243x 28-45 K239-K40 2772.35 2772.37 
207-215x 41-59 K208-K45 3393.69 3393.71 
117-123x 132-149 + H K118-(K140 or K133) 3398.62 3398.66 
117-123x 97-116 + H K118-(K106 or K107) 3878.75 3878.81 
Davidson, 2003 
1-10x 89-96 NT-K94 2294.13 2294.15 
107-116x 117-123 K107-K118 2417.32 2417.4 
84-94x 95-106 K88-K96 2923.59 2923.73 
Bhat, 2005 
D (1–12) K V (11–23) K NT-K12 2861.35 2861.37 
(c) 
Published Intermolecular cross-links 
Davidson, 2003 
Peptide-I Peptide-II Lysines Observed (Da) Theoretical (Da) 
207-215x 207-215 K208-K208 2197.12 2197.13 
132-140x 132-140 K133-K133 2477.24 2477.25 
97-107x 97-107 K106-K106 2933.4 2933.44 
117-123x 134-149 K118-K140 2950.47 2950.48 
132-140x 134-149 K140-K140 3233.59 3233.58 
239-243x 216-238 K239-K226 3373.72 3373.75 
189-206x 62-83 K195-K77 4818.28 4818.42 
Davidson, 2005 
207-215x 207-215 K208-K208 2161.19 2161.21 
84-94x 117-123 K88-K118 2357.2 2357.22 
95-106x 117-123 K96-K118 2457.35 2457.37 
28-45x 239-243 K40-K239 2736.42 2736.44 
117-123x 134-149 K118-K140 2914.56 2914.67 
84-94x 95-106 K88-K96 2923.59 2923.73 
46-61x 207-215 K59-K208 3030.7 3030.8 
216-238x 239-243 K226-K239 3337.96 3338.11 
46-61x 189-206 K59-K195 4046.22 4046.38 
62-83x 189-206 K77-K195 4782.47 4782.57 
Bhat, 2005 
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11–23 178–188  12–182 2792.44 2792.42 
239–243 28–45  40–239 2772.34 2772.34 
117–123 134–149  118–140 2950.46 2950.45 
linker is not considered. Hence, there is a strong possibility that all the possible 
cross-links have not been identified.   
Future cross-linking studies with apoAI should focus on alternative 
cleavage protocols to generate large fragments of cross-linked apoAI molecules. 
Trypsin digestion generates too many peptides of apoAI leading to mass 
degeneracy and complicating the identification of cross-linked apoAI peptides. 
The presence of larger fragments of apoAI increases the chances of identifying 
Figure-31: Comparison of the number of intrapeptide, intramolecular and intermolecular cross-
links in apoAI trypsin peptides in three different reports. The number of peptides identified in each 
report is indicated in the non-overlapping parts of the circles. The number of peptides observed in 
common between the two or three studies is indicated in the overlapping areas of the circles.  
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the cross-linked domains/regions of apoAI. ApoAI has 4 Met residues and 
cleavage at CNBr residues has already been tried, the position of the CNBr 
peptide in apoAI leads to the generation of CNBr peptides that are identical in 
size and will complicate the separation and identification of the fragments. 
Cleavage at Trp residues with BNPS-Skatole can be very useful for this purpose. 
Wild-type apoAI molecule has 4 Trp residues and the fragments of BNPS-
Skatole cleavage are of different sizes and will not complicate the identification or 
separation of the peptides. Currently the possibility of using a mixture of Trp 
mutants and wild-type apoAI for chemical cross-linking is under way and we 
believe that this will lead to the identification of potential intermolecular contacts 
between adjacent apoAI molecules in discoidal lipoprotein molecules. The 
second factor which could lead to better identification of peptides is to switch 
from MALDI-TOF mass spectrometry to LC-ES-QTOF mass spectrometery with 
MS/MS capabilities. MS/MS sequencing of peptides/cross-linked peptides will 
help in the unambiguous identification of peptides even if mass degeneracy 
occurs. Unlike MALDI-TOF mass spectrometry, chemical cross-linking of 
proteins/synthetic peptides and the fragmentation pattern has been well studied 
by using ES-QTOF mass spectrometers(91, 101, 107). This available data will 





Identification of steps in the lipid-binding associated conformational 
flexibility of locust apoLp-III- Utilizing disulfide mutants of locust apoLp-III we 
were able to identify the vital steps during the lipid-binding associated helix-
bundle reorganization of apoLp-III. The separation of helices 1 and 5 is an 
essential step during the lipid-binding process of apoLp-III. The inability helix1-5 
tethered disulfide mutant to interact with any kind of lipid-surface suggests the 
separation of helices 1 and 5 to be an early step during the lipid-binding process 
of apoLp-III.  
ApoLp-III can exist in different conformations in the lipid-bound state-
Thethering helices 3 and 4 or loops 2 and 4 imapirs the lipid-binding activity of 
apoLp-III and leads to the formation of lipoproteins of different sizes as compared 
to the wild-type apoLp-III. This suggests that apoLp-III can adopt different 
conformations in the lipid-bound state. 
Organization of human apoAI molecules in discoidal lipoprotein particles-
The difficulties in utilizing chemical cross-linking, tryspin digestion and peptide 
mass fingerprinting by MALDI-TOF mass spectrometry is discussed. The data 
obtained till date suggests the requirement of alternative cleavage protocols to 
generate larger fragments of cross-linked apoAI and the use of mass 
spectrometers with MS/MS capabilities to identify the cross-linked peptides of 
apoAI.      
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Evidence For The Formation Of Disulfide Bond in ApoLp-III Disulfide 
Mutants 
Gel-shift assay-The formation of disulfide bonds in apoLp-III disulfide 
mutants used in the studies in Chapter-IV was monitored by mobility shift assay 
in SDS-PAGE and increased stability as monitored by thermal and chemical 
denaturation studies. Figure-32 shows the mobility shift observed for the H3-H4 
mutant and L2-L4 disulfide mutants. The presence of a disulfide bond leads to a 
faster mobility of the disulfide mutants as compared to the wild-type apoLp-III 
molecule in SDS-PAGE gel. 
 
Denaturation Studies- In the thermal (Figure-33) unfolding studies apoLp-
III disulfide mutants showed increased stability (increased transition temperature) 
as compared to the wild-type apoLp-III molecule. The thermal unfolding was 
monitored as a decrease in molar ellipticity at 222nm in CD spectroscopy. The 
mid-point of transition from thermal unfolding assays is tabulated in Table-9. The 
Figure-32: Gel-shift assay to monitor the 
formation of disulfide bonds in apoLp-III 
disulfide mutants. 
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increased stability of the oxidized disulfide mutants suggests the formation 
of a disulfide bond. 
 
Table-9: Estimated transition temperatures for apoLp-III wild-type and disulfide mutants from the 
thermal unfolding plots in Figure-33.  





Figure-33: Thermal unfolding of apoLp-III wild-type and oxidized disulfide mutants 
monitored by CD spectroscopy. 
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Appendix-II 
Insect Exchangeable Apolipoprotein-III Forms Discoidal Lipoproteins of 
Discrete Sizes on Reconstitution with Phospholipid/Detergent Mixed 
Micelles. 
Exchangeable apolipoproteins are reconstituted with phospholipids by 
spontaneous interaction or by cholate dialysis to yield discoidal lipoprotein 
complexes of discrete size(s). The size or sizes of the discoidal lipoprotein 
complexes formed depend on the initial protein to lipid-ratio and the conformation 
of apoLp-III in the final lipid-bound state. At a 1:60 ratio of apoLp-III to 
phospholipids wild-type apoLp-III forms two discrete sizes of discoidal 
lipoproteins with 12.2 nm and 10.4 nm Stoke’s diameter while the oxidized H1-H4 
mutant forms discoidal lipoproteins of 17 nm diameter (see native gradient gel 
electrophoresis data Figure-15, Chapter-IV). Here an attempt is made to explain 
the formation of discrete lipoprotein sizes in the apoLp-III/phospholipid 
reconstitution experiments.  
Assuming the 12.2 nm, 10.4 nm discoidal lipoproteins complexes of wild-
type apoLp-III and the 17nm discoidal lipoprotein complexex of oxidized H3-H4 
mutant as perfect cylinders as shown in Figure-34) the lateral surface area of the 
phospholipid bilayer or the surface area of the phospholipid acyl chains available 
for interaction with exchangeable apolipoproteins was calculated by using the 
equation-4.
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Figure-34: The dimensions of a discoidal lipoprotein molecule used to calculate 
the lateral surface area of phospholipid acyl chains. d,diameter and h, thickness of DMPC 
(phospholipid) bilayer. The thickness of a DMPC bilayer is 5nm. 
 
Lateral Surface area = Circumference x thickness (h) of the DMPC bilayer 
 = (π x d) x h (equation-4)
Using the equation for the volume of a cylinder and equation-4 the 
volume and lateral surface area of the phospholipids for the 12.2 nm, 10.4 nm 











6.1 584.197 191.54 19154 
5.2 424.528 163.28 16328 
8.5 1134.325 266.9 26690 
Table-10: Estimated lateral surface area of phospholipid disks. 
The surface area occupied by apoLp-III molecules in the air-water 
interface is used as an approximation of the surface area in the lipid-bound state. 
At the air-water interface apoLp-III molecules were estimated to occupy a surface 
area of 3000Å2/molecule of apoLp-III. Using this value and the estimated lateral 
surface area of the disks in Table-10 there are 5 and 6 apoLp-III molecules in 
d
h 5nmLateral surface area (LSA)
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12.2 and 10.4 nm diameter discoidal lipoprotein particles respectively. The 
difference in the lateral surface area between the 12.2 nm and 10.4 nm diameter 
particles is ~ 3000Å2. This suggests that the binding of apoLp-III to the discoidal 
lipoprotein particles requires sufficent lateral surface area to accommodate an 
extended apoLp-III molecule.  Considering the possibility of 6 apoLp-III 
molecules in the smaller 10.4 nm particle then there will be an excess of 
extended apoLp-III molecule(s) not bound to the lipoprotein surface. In the case 
of 5 molecules bound to the large 12.2 nm particle the apoLp-III molecule cannot 
occupy the entire lateral surface area and the hydrophobic acyl chains will be 
exposed to aqueous buffer. Based on the stochiometry and lipid-bound 
conformation the apoLp-III molecule forms lipoproteins of discrete sizes so as to 
accommodate optimal number of apoLp-III molecules on the lateral surface area 
of exposed acyl chains. 
Still, this does not explain the large size of the discoidal lipoprotein 
complex formed by oxidized H3-H4 mutant. In Table-10 the volume of 17 nm 
diameter H3-H4 mutant disks to be double that of the 10.4 nm wild-type 
lipoprotein particles but the lateral surface area of the 17 nm complex just 
increases by ~1.3 fold. This suggests that with increase in the phospholipid 
content and eventually the volume of the cylindrical phospholipid bilayer, there is 
a comparably lesser change in the lateral surface area available for apoLp-III 
binding and requires the binding of lesser number of apoLp-III particles per unit 
area of exposed acyl chains.This is consistent with the observed data in 
Chapter-4 where ~50% of  oxidized H3-H4 mutants  did not bind to 
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cholate/phospholipid mixed micelles and form discoidal lipoproteins. The 
tethering of helices 3 and 4 in the H3-H4 mutant could prevent the mutant from 
adopting a fully extended conformation like the wild-type apoLp-III hence the 
surface area occupied by the H3-H4 in the discoidal lipoproteins will be lesser as 
compared to the wild-type. The large size of the lipoprotein complexes formed 
suggest that at 1:60 protein: phospholipid ratio used for making lipoproteins the 
H3-H4 mutant binds to the same number of phospholipids as compared to the 
wild-type apoLp-III by forming large lipoprotein complexes.  
 
VITA 
Palaniappan (Chetty) Sevugan Chetty 
246 Noble Research Center 







Doctoral Candidate, Department of Biochemistry and Molecular Biology, 
Oklahoma State University, Stillwater, OK, 74074. Oct 2000- Present (Tentative 
Graduation Date- April 2006). 
Thesis Advisor: Jose L. Soulages 
 
CURRENT RESEARCH: 
Elucidating the structure-function relationship of insect apolipophorin-III and 
human apolipoprotein AI utilizing chemical cross-linking and mass-spectrometry. 
The ultimate goal of my research is to elucidate the lipid-bound conformation of 
insect and human exchangeable apolipoproteins.  
EDUCATIONAL QUALIFICATION:
COMPLETED THE REQUIREMENTS FOR THE PHD DEGREE AT 
OKLAHOMA STATE UNIVERSITY IN MAY, 2006. 
 
Master of Science, Medical Biochemistry, Maharaj Sayaji Rao University, 
Baroda, Gujarat, India. June 1996- January 1999 
Masters Thesis: Measuring Oxidative Stress during Myocardial Infarction. 
Study involved monitoring the serum levels of calcium, magnesium, zinc, copper 
and malondialdehyde in patients of acute myocardial infarction. 
Bachelor of Science, Botany, Loyola College, University of Madras, Chennai, 
Tamil Nadu, India. April 1993- April 1996 
Bachelor’s Thesis: Impact of Acid Fast Dyes on Fresh Water Fishes. Study 
investigated the effect of tannery effluents on the life-cycle of fresh water fishes. 
 
PROFESSIONAL EXPERIENCE: 
Mass Spectrometry Research Assistant, Protein-DNA Core Facility, 
Department of Biochemistry and Molecular Biology, Oklahoma State University, 
Stillwater, OK. July 2003 – Jan 2004. 
Job Responsibilities 
Establishing a Standard Operating Procedure for MALDI-TOF analysis  
Processing client samples for MALDI-TOF Mass Spectrometry 
Aquiring data in a Voyager-DE Pro MALDI-TOF Mass Spectrometer 
Analyzing Mass spectrometry data of biomolecules and preparing reports for 
clients 
 
Trainee Clinical Lab Assistant, S.V.P Hospital, Chennai, Tamilnadu, India. Jan 
1999-Jan 2000 
Job Responsibilities 
Receiving/ collecting samples from patients 
Performing routine clinical tests on human body fluids 
Creating reports of clinical tests for medical doctors 
 
RESEARCH SKILLS 
Protein expression and purification 
LC and RP-HPLC for separation of proteins and peptides 
Chemical Cross-linking of proteins, enzymatic and chemical cleavage of proteins 
MALDI-TOF mass spectrometry for peptide mass fingerprinting 
 
SERVICE, ACCOMPLISHMENTS & AWARDS 
Vice-President, Biochemistry and Molecular Biology Graduate Student 
Association, Oklahoma State University (spring 2002-spring 2003) 
Student Faculty Representative, Biochemistry and Molecular Biology Graduate 
Student Association Fall 2005-Present 
Web master for Biochemistry and Molecular Biology Graduate Student 
Association at Oklahoma State University (Spring 2002 to Present) 
$ 500.00 award for (Second Place) best poster presentation in the Fall 2005 
Biochemistry and Molecular Biology Graduate Student Association Annual 
Research Symposium 
 
